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INTRODUCTION 
 
Community-acquired pneumonia (CAP) remains a significant cause of morbidity, 
mortality, and an economic burden [1]. In low - to middle - income countries, it is one of 
the most important causes of death and loss of years of life [2,3]. Of the 15 million deaths 
reported for the year 2004 in Southeast Asian countries (as defined by WHO), 1.5 million  
(10 %) were due to respiratory infections, mostly lower respiratory tract infections, 
including 0.5 million deaths due to tuberculosis. Likewise, these infections were 
responsible for over 40/440 million disability adjusted life years lost in this area of the 
world [3]. 
Knowledge about the epidemiology, etiology and pathogenesis of CAP is essential for 
patient management in order to achieve the optimum patients’ outcomes [4]. As 
antibiotic therapy is one of the cornerstones in the management of patients with 
infections including CAP, the quality of care, in particular the quality of the use of  
antibiotics, is also crucial in the management of CAP cases [5].  Although host factors such 
as age and gender, and severity of disease on presentation, are the most important 
determinants of outcome of CAP, patients with CAP also need to be identified and 
empirically treated at an early stage of their illness since delay in the timely instigation of 
appropriate empirical antimicrobial therapy for CAP has been independently associated 
with poor patient outcomes [6]. 
CAP is often caused by pathogens that have colonized the upper airways prior to 
causing lower respiratory disease. This has been proven for Streptococcus pneumoniae. 
Therefore, the commensal microflora of the upper respiratory tract, especially the 
nasopharyngeal space needs to be studied in detail. 
Indonesia is the world’s fourth most populous country, with a population of close to 
250 million inhabitants. In Indonesia, CAP ranks the first as the cause of mortality in 
children [7] and the sixth in adults [8]. However, there are still very few data available 
with regard to CAP in Indonesia. Data are lacking on the etiology, antimicrobial 
management, and supportive patient care, leading to difficulties in controlling this 
disease, and, consequently, to a potentially enhanced burden from this disease. Also, the 
normal nasopharyngeal microflora of Indonesian inhabitants has received little attention 
so far. These are in sharp contrast to the many experiences with this disease and with 
nasoparyngael carriage reported from western countries, and even from some countries 
neighbouring Indonesia [9-11]. Consequently, the management of CAP patients in 
Indonesia has been, so far, based on experience gained elsewhere and presented in 
international guidelines [8] without evaluation of their appropriateness for the 
Indonesian setting. There is also, to our knowledge, no proper evaluation of the 
outcomes of patients with CAP in this country. 
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Therefore, the general aim of the studies presented in this thesis was to address 
issues necessary to improve the outcomes for patients with CAP requiring hospaital 
admission in Indonesia. More specifically we aimed to better delineate the spectrum of 
etiologies of CAP in adult patients in Indonesia, to evaluate the level of appropriateness 
of antibiotic management of patients with CAP, and of other supporting measures which 
can be implemented in the Indonesian setting. Nasopharyngeal carriage of pneumococci 
and of Gram-negative enteric bacilli among healthy children and adults was also 
addressed, since these bacterial species were the commonest agents of bacterial CAP in 
this area of the world. 
 
OUTLINE OF THE THESIS 
 
The main questions to be answered in this thesis were addressed in two major 
studies, i.e. the CAPSIN (Community-Acquired Pneumonia Study in Indonesia) project and 
the Nasopharyngeal Colonization Study (NASCO), and included: 
1. What are the pathogens causing CAP in Indonesia? What is the frequency of 
antimicrobial resistance of clinical bacterial isolates of CAP in Indonesia? Is there 
an association between the etiology and the underlying diseases, severity of 
disease, and mortality? 
2. What is the frequency of nasopharyngeal carriage of the most common 
respiratory pathogens in healthy people in Indonesia? What is the frequency of 
antimicrobial resistance of strains carried by healthy individuals? What are the 
risk factors for throat carriage of the major respiratory pathogens? 
3. What are the characteristic differences between respiratory pathogens isolated 
from colonized but otherwise healthy individuals versus those obtained from 
infected individuals? 
4. How should the management of patients with CAP (in particular, with regard to 
antibiotic therapies) be evaluated? What are the results of such an evaluation in 
an Indonesian hospital? 
 
To address these questions, the content of the thesis is presented in five sections.  
 
Part I: Background 
In chapter 2, a review of the published literature on CAP in Southeast Asia is 
presented. This review focuses on the most recent data.  
 
Part II: Etiology of community-acquired pneumonia in Indonesia 
In chapter 3, the etiology of CAP in a large cohort of adult patients hospitalized with a 
clincial diagnosis of CAP in two acute care hospitals in the city of Semarang, the capital of 
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Central Java province, Indonesia, is presented. The etiological diagnosis was determined 
based on a comprehensive range of diagnostic laboratory tests and interpretation of 
these test results by integrative panel discussions involving clinicians, radiologists, and 
clinical microbiologists. One of the implicated pathogenic species, Leptospira spp., is 
discussed separately in chapter 4. 
 
Part III: Characteristic differences between isolates from colonized and infected 
individuals 
Pneumonia, especially bacterial pneumonia, is usually preceded by colonization of the 
upper respiratory tract by potential lower respiratory pathogens. A population-based 
survey of nasopharyngeal carriage of  Streptococcus pneumoniae, Klebsiella pneumoniae, 
and other Gram-negative bacilli among healthy individuals is described in chapter 5 and 
chapter 6. The risk factors for carriage of these potential pathogens are analyzed. The 
heterogeneity among isolates from the major bacterial Gram-negative respiratory 
pathogen, i.e. K. pneumoniae, isolated from healthy and infected individuals is presented 
in chapter 7. 
 
Part IV:  Management of community-acquired pneumonia in Indonesia 
Chapter 8 describes the development of a set of quality indicators for the assessment 
of the medical management of CAP patients in the Indonesian setting.  
 
Part V:  Discussion  
The main findings of the studies in this thesis are discussed and suggestions for 
further research regarding the management of CAP in Indonesia are given in chapter 9 
and summarized in chapter 10. 
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ABSTRACT 
Aim  
Assessment of the information about community-acquired pneumonia (CAP) in Southeast 
Asia, with focus on epidemiology, clinical presentation, etiology, risk factors of acquiring 
CAP, treatment and outcome in order to develop policies including guidelines which are 
suitable for the Southeast Asian setting. 
Methods 
Systematic review of the literature published between 2000 and 2010 reporting on CAP 
among adults in Southeast Asia. 
Results 
Out of 324 publications retrieved in the initial selection, only 22 were identified as 
appropriate for assessment; still some of the 22 selected papers had methodological 
limitations. CAP  was a significant health burden with high morbidity and mortality in this 
region. The most common etiological agents were Klebsiella pneumoniae, Streptococcus  
pneumoniae, Chlamydia  pneumoniae,  Mycobacterium  tuberculosis,  Haemophilus 
influenzae and Mycoplasma pneumoniae. Mixed infections were common. The 
prominence of  Gram-negative bacilli as etiological agents raises questions about the 
validity of current international CAP guidelines for this region. Antibiotic resistance could 
not be assessed due to small numbers and non-standardized methods. 
Conclusion 
Further studies with standardized methodology are needed in order to develop a region-
specific CAP guideline that will result in improvement of outcome of the disease in this 
area. 
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INTRODUCTION 
 
Community-acquired pneumonia (CAP)  is an important health problem due to the 
mortality and morbidity it entails [1]. The World Health Organization [2] ranks acute 
respiratory illness including pneumonia and influenza as the top infectious disease killers, 
worldwide causing 3.5 million deaths/year  [3].  Many investigations have been done and 
many guidelines have been developed, primarily in western, or developed countries, e.g.  
by the British Thoracic Society [4] [5], American Thoracic Society (ATS) [6], Dutch Working 
Party on Antibiotic Policy (SWAB) [7],  the Spanish  Society of Pulmonology and Thoracic 
Surgery (SEPAR) [8], and CAPNETZ- Germany [9]. These guidelines discuss epidemiology of 
324 pathogens,  the use of prediction rules for outcome to decide about treatment at 
home or in hospital, diagnostic procedures and treatment. The question is whether 
guidelines and prediction rules based on conditions in developed countries are applicable 
to the situation in other parts of the world, including Southeast Asia which is dominated 
by developing countries. Differences in etiology and health care facilities might limit the 
usefulness of these guidelines. 
The aim of the present systematic review is to assess the information about CAP in 
Southeast Asia, with focus on epidemiology (incidence, mortality, seasonality), clinical 
presentation (severity of disease, radiological findings), etiology (laboratory methods, 
causative agents, clonality or typing of microorganisms, resistance to antimicrobial agents, 
virulence characteristics), risk factors of acquiring CAP and of poor outcome of CAP.    
 
METHODS 
 
Literature was searched from the databases of the National Centre for Biotechnology 
Information, US National Library PubMed references, Embase, and Web of Science, using 
key words: community-acquired, and pneumonia or pulmonary inflamm or lung inflamm 
or pleuropneumoni or bronchopneumoni, and Southeast Asia, or Southeastern Asia or 
Borneo or Brunei or Cambodia or Timor or Indonesia or Laos or Lao or Laot or Malaysia or 
Mekong or Myanmar or Burma or Burmes or Papua or Philippine or Singapore or Thai or 
Vietnam or Viet-nam and respiratory pathogen, or Streptococcus pneumonia or 
pneumococc or Klebsiella pneumonia or Chlamydia pneumonia or Chlamydophila 
pneumonia or Mycoplasma pneumonia or Haemophilus influenza or Hemophilus influenza  
or Burkholderia pseudomallei or Pseudomonas pseudomallei or melioidosis or Gram-
negative rod or Staphylococcus aureus or influenza or parainfluenza or Mycobacterium 
tuberculosis.   
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RESULTS 
The search yielded publications. Selection of publications was done in three steps, each 
step was done by two reviewers independently. The first step was to select articles 
written in English, published between 2000-2011, with an abstract available, reporting 
specifically about CAP in adults residing in one of the Southeast Asian countries, and being 
not a review or case report.  Seventy-one articles met those criteria and proceeded to the 
second step, i.e. selection of articles which seem to provide significant information on at 
least one of the following topics: epidemiology (incidence, mortality, seasonality), clinical 
presentation (severity of disease,  radiological findings), etiology (causative agents, 
clonality or typing of agents, resistance to antimicrobial agents, virulence characteristics), 
risk factors for acquiring CAP or poor outcome, and treatment of CAP.  Forty-three articles 
were selected by agreement between the two reviewers.  The third step was to analyse 
the selected papers in detail for data extraction.  Eleven articles were excluded because 
these selected CAP patients based on pre-defined laboratory tests, including melioidosis  
[10], Acinetobacter baumannii [11], H1N1-positive patients [12], low titer antibody to 
H5N1 [13], pneumococcal pneumonia  [14], penicillin-resistant S. pneumoniae  [15,16], K. 
pneumoniae  [17], severe acute respiratory syndrome (SARS) [18], and C. pneumoniae 
[19,20] without specifying  numbers relative to the total number of the included CAP 
patients. Three articles were excluded because these studied specific isolates, instead of 
CAP patients [21-23]. Three  papers were excluded because of confusing data 
presentation in the tables and/or text [24-26]. Four other papers were excluded because 
of mixing data of CAP patients with other lower respiratory tract infections (LRTI) [27], 
mixing data for  Southeast Asian countries or with other Asian countries [28,29], and data 
overlapping with other included papers [30]. 
Finally, 22 articles remaining were included, with seven of them not to be included in 
the etiology section because these papers did not study the etiology [31-33] or did not 
give sufficient information about the methods of tests and/or interpretation of test results 
[34-37]. Thirteen articles were from Thailand [31,36-47], five from Malaysia [35,48-51] 
and four from Singapore [32-34,52]. Two more papers from Thailand and Singapore  were 
selected from the reference lists of the selected papers  [53,54]. 
 
Definitions 
Different definitions of CAP were used in the articles. For the review, we defined CAP as 
the presence of new infiltrate(s) on the chest X-ray with at least three of the following: 
respiratory symptoms (coughing, sputum production, dyspnea) or signs of involvement of 
other organs (abdominal symptoms, decreased consciousness), acute onset of disease 
within 14 days of inclusion, and  community origin (no hospitalisation within the last 4 
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weeks, manifestation not later than 48 hours after hospitalization,  no stay in a nursing or 
rehabilitation institute). The definitions used in the included studies are largely consistent 
with this definition. 
Adult was defined as being  >15 [36,41,43-48], >12 [24,35,49-51],  >18 [42],  or >19 
years old [40].  Some studies did not specify the age range [32-34,38,52], however in these 
studies, the median age ranged  from 55 to 68 years. One study included all ages, from 
which we selected the data of the patients aged 17 years old or more [39]. We reviewed 
data of patients >12 years old. 
 
Epidemiological findings 
Incidence  
Three articles presented information about the incidence of CAP in Southeast Asia, all 
from Thailand [31,36,53]. A passive surveillanve performed in 1999-2001 found an overall 
incidence of 236/100.000 people in Thailand, and 211/100.000 in Sa Kaeo province. The 
incidence was highest among children <5 year-old (1,418 per 100,000), decreasing to rates 
between 28 and 264 /100,000 in persons aged 5-65 years, then increasing to 551/100,000 
in persons >65 year-old [53]. The incidence was remarkably higher when determined by 
active surveillance in 2002-2003 in the same province: overall  394/100,000 for 
hospitalized CAP and 495/100,000 when the rate was adjusted for health care seeking 
behaviour. The incidence rate for person over 65 years of age was 1,310/100.000 for 
hospitalized CAP and 2,095/100,000 when adjusted for health care seeking behaviour 
[36]. The same active surveillance method in another Thai province (Nakhon Phanom) in  
2003-2004, involving more househoulds (2,000 vs 1,600 households), found higher overall 
incidence rates of 485/100,000 people per year for hospitalized CAP and 831/100,000 
people per year when adjusted for health care seeking.  The incidence of pneumonia was 
also highest among children <5 years old (2,783/100,000 for hospitalized CAP and 
5,321/100,000 when adjusted for health care seeking), decreasing to 296/100,000 people 
(for hospitalized pneumoniae) and 443/100,000 people (when adjusted for health care 
seeking behaivour) in people aged 5-15 year-old,  180/100,000 (for hospitalized 
pneumonia) and 261/100.000 (when adjusted for health care seeking behaviour) in 
persons 15-64 year-old, then increasing dramatically  in elderly >65 year-old to 
1,573/100,000 (for hospitalized pneumonia) and 4,723/100,000 people (when adjusted to 
health care seeking behaviour)[31].  
A study investigating severe CAP caused by atypical bacteria in adults in Sa Kaeo 
province found for Legionella longbeacheae an incidence of 7–45/100,000 population, for 
Mycoplasma pneumoniae of 4.2–23/100,000 population, and for Chlamydia pneumoniae 
of  27–176/100,000 population (Phares et al., 2007). 
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weeks, manifestation not later than 48 hours after hospitalization,  no stay in a nursing or 
rehabilitation institute). The definitions used in the included studies are largely consistent 
with this definition. 
Adult was defined as being  >15 [36,41,43-48], >12 [24,35,49-51],  >18 [42],  or >19 
years old [40].  Some studies did not specify the age range [32-34,38,52], however in these 
studies, the median age ranged  from 55 to 68 years. One study included all ages, from 
which we selected the data of the patients aged 17 years old or more [39]. We reviewed 
data of patients >12 years old. 
 
Epidemiological findings 
Incidence  
Three articles presented information about the incidence of CAP in Southeast Asia, all 
from Thailand [31,36,53]. A passive surveillanve performed in 1999-2001 found an overall 
incidence of 236/100.000 people in Thailand, and 211/100.000 in Sa Kaeo province. The 
incidence was highest among children <5 year-old (1,418 per 100,000), decreasing to rates 
between 28 and 264 /100,000 in persons aged 5-65 years, then increasing to 551/100,000 
in persons >65 year-old [53]. The incidence was remarkably higher when determined by 
active surveillance in 2002-2003 in the same province: overall  394/100,000 for 
hospitalized CAP and 495/100,000 when the rate was adjusted for health care seeking 
behaviour. The incidence rate for person over 65 years of age was 1,310/100.000 for 
hospitalized CAP and 2,095/100,000 when adjusted for health care seeking behaviour 
[36]. The same active surveillance method in another Thai province (Nakhon Phanom) in  
2003-2004, involving more househoulds (2,000 vs 1,600 households), found higher overall 
incidence rates of 485/100,000 people per year for hospitalized CAP and 831/100,000 
people per year when adjusted for health care seeking.  The incidence of pneumonia was 
also highest among children <5 years old (2,783/100,000 for hospitalized CAP and 
5,321/100,000 when adjusted for health care seeking), decreasing to 296/100,000 people 
(for hospitalized pneumoniae) and 443/100,000 people (when adjusted for health care 
seeking behaivour) in people aged 5-15 year-old,  180/100,000 (for hospitalized 
pneumonia) and 261/100.000 (when adjusted for health care seeking behaviour) in 
persons 15-64 year-old, then increasing dramatically  in elderly >65 year-old to 
1,573/100,000 (for hospitalized pneumonia) and 4,723/100,000 people (when adjusted to 
health care seeking behaviour)[31].  
A study investigating severe CAP caused by atypical bacteria in adults in Sa Kaeo 
province found for Legionella longbeacheae an incidence of 7–45/100,000 population, for 
Mycoplasma pneumoniae of 4.2–23/100,000 population, and for Chlamydia pneumoniae 
of  27–176/100,000 population (Phares et al., 2007). 
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Risk factors for developing CAP 
No publications were found  about the risk of developing CAP in Southeast Asian 
countries. Some papers studied the risk of developing severe CAP  as discussed in the 
paragraph about severity of disease (see below). 
 
Seasonality 
Two  studies reported seasonal variation in the occurrence of CAP [36,39]. The incidence 
of CAP peaked twice per year in Thailand, namely in January to March and in June to 
September.  The latter study found that the first peak  was dominated by parainfluenza 
virus, influenza virus A/B, and bocavirus infections, while the second peak was dominated 
by respiratory syncytial virus (RSV), human metapneumovirus (hMPV), adenovirus, and 
influenza virus A/B infections (Olsen et al., 2006). Rhinoviruses were identified throughout 
the study period with no distinct seasonality. None of the other studies mentioned 
seasonality in the incidence of CAP. 
 
Clinical Presentation 
Radiology  
The diagnosis of pneumonia requires the presence of infiltrate(s) on a chest X-ray, 
however, the description, interpretation and classification of abnormalities seen on chest 
X-rays shows large variation, making it difficult to summarize the radiological 
manifestations seen in patients with CAP. A simple categorization might be useful to 
describe the abnormalities seen on the chest X-rays into alveolar infiltrates including 
localized alveolar infiltrate [39,40,43],  patchy alveolar lesions [43], lobar infiltration, 
bilateral alveolar or multilobar infiltration [47], alveolar shadowing [46,55], and  diffuse 
non-localized abnormalities such as interstitial infiltrates [36,39,40,42,45,47,51]. The 
alveolar infiltrates accounted for 30-90% of the pneumonia, while interstitial infiltrates 
ranged from 10-74%.  The combination of alveolar and interstitial infiltrates was seen in 3-
24% of the X-rays [39,42,45]. Other abnormalities reported were  pleural effusions, 
ranging from 3-17.6%   [39,45,46]. 
Six papers attempted to associate the radiological images with etiology, clinical 
findings from chest auscultation, and outcome. Two studies found no association between 
radiological image and etiology with regard to atypical pneumonia in adults [40,41], but in 
children lobar consolidation was associated with atypical pneumonia [40]. For 
tuberculosis, the upper lobe involvement and cavities were specific radiological findings 
[49,50]. Alveolar infiltrates were associated with rales, crepitations, ronchi, and 
hemoptysis, while interstitial infiltrates were associated with wheezing [36]. Multilobar 
involvement was associated with mortality [47,50].  
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 Severity 
Thirteen articles gave information about the severity of CAP using several methods. The 
ATS criteria were used in most studies, but different versions of the criteria were used 
dating from 1993 [56], 2001 [57] or 2007 [6]. Two studies used both major and minor 
criteria of the 2007 version [38,52], one of which also used the logistic organ dysfunction 
score (LODS) for intensive care patients to predict mortality [52]. Two studies used both 
major and and minor criteria of the 2001 version [43,44]. Two studies [32,34] used the 
minor criteria of the 2007 version, one of which compared it with the Pneumonia Severity 
Index (PSI) [58] and CURB-65 (consciousness, urea, respiratory rate, blood pressure, age 
65) score [59]. One study [46] used the 1993 version [60]. One study used own criteria 
which were compatible with the major criteria of the 2001 and 2007 versions [33], one the 
BTS 2001 score [35] which included confusion, uremia, respiratory rate > 30x/minutes, 
and low blood pressure (systolic < 90mmHg or diastolic <60mmHg (CURB) , one the 
APACHE II score (Acute Physiology and Chronic Health Evaluation II, a severity score for 
patients admitted to ICU [61]) [37], and one a self developed score [51]. 
The incidence of  severe pneumonia ranged 17-50% depending on the scoring 
methods. The PSI classified more cases (50%) as severe than the IDSA/ATS 2007 minor 
criteria (27%) or CURB-65 (23%) did, however the IDSA/ATS 2007 minor criteria had 
greater discriminatory power for mortality [32].  
Next to the scoring methods for severity, the incidence of severe CAP depended also 
on patient caracteristics. In patients over 65 years old [33,34,38] and in patients with 
underlying diseases such as congestive heart diseases, chronic obstructive pulmonary 
diseases, hypertention, cerebrovascular diseases and diabetes melitus higher rates of 
severe pneumonia were seen [24,38], although not all studies confirmed the association 
between severity of CAP and underlying diseases [34] and smoking [35]. A study in 
Thailand in 2011 found that pathogens were not found to be determinants of severity 
[38]. However another study from the same country in 2003 found that GNB caused more 
severe CAP than Gram positive cocci or atypical bacteria [45] 
 
Etiology   
Diagnostic methods 
Appropriate information about the microbiological tests used in the studies is needed for 
correct interpretation of the etiological findings. Unfortunately, only limited information 
about the microbiological methods is given in many of the reviewed articles. In addition, 
most of the reviewed studies  limited the diagnostic tests to few specific agents: only 
(typical) bacteria (with or without  M. tuberculosis) [24,34-36,52], only atypical bacteria 
[40,41], or only typical and atypical bacteria [42-45,47-51].  Just two studies applied tests 
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criteria (27%) or CURB-65 (23%) did, however the IDSA/ATS 2007 minor criteria had 
greater discriminatory power for mortality [32].  
Next to the scoring methods for severity, the incidence of severe CAP depended also 
on patient caracteristics. In patients over 65 years old [33,34,38] and in patients with 
underlying diseases such as congestive heart diseases, chronic obstructive pulmonary 
diseases, hypertention, cerebrovascular diseases and diabetes melitus higher rates of 
severe pneumonia were seen [24,38], although not all studies confirmed the association 
between severity of CAP and underlying diseases [34] and smoking [35]. A study in 
Thailand in 2011 found that pathogens were not found to be determinants of severity 
[38]. However another study from the same country in 2003 found that GNB caused more 
severe CAP than Gram positive cocci or atypical bacteria [45] 
 
Etiology   
Diagnostic methods 
Appropriate information about the microbiological tests used in the studies is needed for 
correct interpretation of the etiological findings. Unfortunately, only limited information 
about the microbiological methods is given in many of the reviewed articles. In addition, 
most of the reviewed studies  limited the diagnostic tests to few specific agents: only 
(typical) bacteria (with or without  M. tuberculosis) [24,34-36,52], only atypical bacteria 
[40,41], or only typical and atypical bacteria [42-45,47-51].  Just two studies applied tests 
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to detect a wider range of respiratory pathogens, including typical and atypical bacteria, 
M. tuberculosis, viruses, with or without fungi [38,39]. Therefore, the percentage of 
patients with unknown etiology in most studies was high, up to 70%  and over (Table 1). 
The tests for the detection of etiological agents varied, for instance,  S. pneumoniae 
was diagnosed using cultures [38,42-46,48,52], PCR [48],  urinary antigen test 
[39,42,45,50,51],  serum antigen test [50,51] or the finding of Gram positive cocci in 
combination with a favorable clinical respons to intravenous penicillin G within a few days 
[47].   
 As sputum samples are not free from contamination by microorganisms colonizing the 
throat and oral cavity, measures are necessary for correct interpretation for sputum 
cultures, in particular to discriminate between colonization and infection, for instance by 
assessing sputum quality, combining microscopy and culture, or (semi-) quantifying of 
sputum cultures. Only some papers described such measures [42,45,49-51]. The 
interpretation criteria also varied. Some studies classified sputum cultures  as positive 
when the bacteria showed heavy or moderate growth and were predominant on the plate 
[49], or when the growth was consistent with the Gram stain [42,45], or when the 
identification yielded non-respiratory tract colonizing species [51]. Other studies 
considered all isolates from sputum to be pathogenic without specific criteria [47,50]. 
Inappropriate measures to discriminate colonization from infection lead to reporting 
microorganisms which are usually not considered as respiratory pathogens, including 
Staphylococcus capitis [38], Staphylococcus epidermidis [38], Streptococcus viridans 
[25,45], and  Acinetobacter lwoffii [38].  In some papers, some microorganisms were 
identified only to genus level, leading to interpretation bias, since only few species of the 
genuses cause pneumonia, e.g. Streptococcus spp. [43,45,50,51], Klebsiella spp. [50-52], 
Citrobacter spp. [49],  Pseudomonas spp. [25,35,39,42,45] , Enterobacter spp. [35,51],  
Burkholderia spp.[36], Acinetobacter spp. [35,45,47,50,52], Legionella spp. [39,52], 
Leptospira spp. [52], and diphteroid bacilli [38] or Corynebcterium spp.[34], β-hemolytic 
Streptococcus non A/non B [42], and  anaerobic bacteria [45]. Moreover, the identification 
of Acinetobacter baumannii  [24,38,42,45,47,52] was not confirmed with appropriate 
molecular tests, such as PCR  (blaOXA-51-like) [62].  
A variety of serological tests with different criteria for interpretation of the results 
were used in thirteen papers [39-51], all considered a four-fold or higher increase of the 
antibody titer as proof for a definite diagnosis. In addition, some studies used other 
criteria, such as a single high titer, mostly as evidence for presumptive etiology [39-
42,48,49]. However, some papers used this criterion for a definite etiological diagnosis 
[45,47,51]. The use of this criterion for definite diagnosis needs careful clinical evaluation, 
as the cut off point for positivity may differ among different populations and this may 
compromise the value of the test [29]. Another criterion was a high persistent 
immunoglobulin titer  accompanied by a positive (qualitative) PCR  [41]. Some studies also 
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used a qualitative serology test, in which the results are interpreted as positive or negative 
without antibody titer measurement  [39,48]. Urinary antigen test for S. pneumoniae [39] 
and L. pneumophila [39,42,45] were used in few studies. 
Since the information about laboratory tests and their interpretation is lacking in most 
studies, and the methodology and interpretation between studies differs considerably, it 
is difficult to compare the results among the studies, and impossible to combine data to 
calculate overall rates of pathogens in patients with CAP in Southeast Asia.  
 
Causative agents 
Table 1 summarizes the etiological agents from studies that reported at least the type of 
laboratory specimens and the test methods, that were consistent when presenting data in 
tables and text, and allowed calculation of percentages. 
Table 2 displays pathogens that were found as single pathogens, and Table 3 
pathogens that were found as co-pathogens. Table 4 presents the most frequently found 
agents disregarding the variation in the diagnostic tests applied. Species that are not 
commonly considered as respiratory pathogens, or identified only as genus, and species 
with very low incidence (reported in small numbers in limited studies) were excluded from 
the summary in the tables. 
Assuming that all pathogen identifications were valid, K. pneumoniae was the most 
common etiology of CAP in Southeast Asia (9.8 % on average, range 4-17%), mostly (76%) 
as a single pathogen, as reported in 10 studies. In 24% of cases, K. pneumoniae was  part 
of a mixed infection in combination with H. influenzae, S. aureus,  B. pseudomallei, L. 
pneumophila, C. pneumoniae,  M. pneumoniae,  S. pneumoniae, E. coli,  and P. aeruginosa  
[38,42-45,47-51], influenza virus H3N2  and the fungus Penicillium marneffei [38]. S. 
pneumoniae  was the second most common etiology reported  in 12 studies, with an 
overall incidence rate of 9.2%  (range 1-27%), mostly (80%) being the single pathogen. The 
true incidence of pneumococcal disease was probably higher since most papers used only 
cultures to diagnose S. pneumoniae. In 20% of cases, S. pneumoniae was seen in 
combination with other typical bacteria (H. parainfluenzae, K. pneumoniae, P. aeruginosa 
and M. catarrhalis, B. pseudomallei) or with atypical bacteria (C. pneumonia,  L. 
pneumophila) [42-45,48]. 
C. pneumoniae  was the third most common agent,  reported in  8 papers with an 
overall incidence rate of  8.4 % (range 4-36%). In 55% of the patients C. pneumoniae was 
the single pathogen and in 45% a co-pathogen.  The incidence of infection by C. 
pneumoniae was higher (22 and 36%) in non-hospitalized CAP patients [42,45], than the 4-
16% in hospitalized patients [39,43,48,49]. 
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The Gram-negative bacilli (GNB) other than K. pneumoniae and B. pseudomallei  (E. 
coli, Enterobacter spp., Klebsiella spp., P.aeruginosa, A. baumannii, Acinetobacter spp.  
and P. multocida), together took up the fourth place  with an overall incidence of  7.2 % 
(range 3-15%). In 72% of cases these other GNB were the single pathogen and in 28% GNB 
occurred in combination with other pathogens [38,42-45,47-52].  
M. tuberculosis was investigated in only 6 studies in which the overall incidence was 
6.3% (range 1-19%) [38,39,47,49,50,52], making it the fifth most common pathogen. Two 
papers did not clearly indicate whether the absence of M. tuberculosis in their results was 
because they did not test the presence of this pathogen, or because this pathogen was 
not found in their patients [44,51].   
B. pseudomallei  and H. influenzae  had similar incidence rates, 5.7%  and 5.5%, 
respectively. However, these two pathogens differed in occurrence with regard to severity 
of CAP.  H. influenzae had the highest incidence rate (59%)  in out-patients [42], while B. 
pseudomallei  was hardly isolated from  outpatients [42,45]. B. pseudomallei  incidence 
ranged  from 2-19%  in patients from  Thailand, Malaysia, and Singapore and was 
associated with severe  CAP [43,44,51,52]. 
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Antimicrobial  susceptibility 
Four papers provided information about antimicrobial susceptibility of bacteria 
[35,42,45,47]. Two of them contained sufficient information on the susceptibility testing 
methods and the reference values  [42,45]; however, only one used control strains [42]. A 
paper from Thailand testing susceptibility of pneumococcus to penicillin using an E-test 
reported that 37% of S. pneumoniae isolates were penicillin non-susceptible (PNSP) with 
no significant differences with regard to age, sex, co-morbidity or mortality [45]. Another 
Thai study found a lower incidence of PNSP (13%) with all S. pneumoniae strains 
susceptible to the  first generation cephalosporins [47]. However, the latter paper did not 
give any information about the methods used, making it questionable whether the data 
are comparable.  
The third study also found lower incidence of PNSP (17%) [42]. However, this study 
used a disk diffusion method, which according to NCCLS/CLSI should only be used for 
screening of  PNSP, and is not a standard for establishing the diagnosis of PNSP.  The 
fourth paper did not report the  susceptibility of pneumococcus since the study found only 
Gram negative pathogens [35].  
The study from Thailand [42] showed a high percentage of H. influenzae non-
susceptible to cotrimoxazole (64%) and erythromycin (57%), and of H. parainfluenzae non-
susceptible to cotrimoxazole (58%) and erythromycin (92%).  Another paper also indicated 
the problem of H. influenzae non-susceptibility as 34% of the strains were nonsusceptible 
to erythromycin and 47% to cotrimoxazole. Still, all H. influenzae isolates were susceptible 
to chloramphenicol, cefuroxime and clarithromycin [47]. No information was given 
regarding the method of susceptibility testing in this study. 
Susceptibility profiles of K. pneumoniae strains were reported by two studies. One of 
these studies reported that extended-spectrum beta-lactamase (ESBL) producing strains 
were found in 6% of GNB isolates [35] with no information about the test method. The 
other study reported that all strains were sensitive to the third generation cephalosporins, 
and to gentamicin, and amikacin [47]. In the latter study, B. pseudomallei strains were 
susceptible to ceftazidime, cotrimoxazol, chloramphenicol and cefoperazone/sulbactam 
[47]. This study also reported a single isolate of S. aureus that was oxacillin resistant 
(16%), but confirmatory tests for methicillin-resistant S. aureus (MRSA) were not 
performed.  
 
Clonality and virulence factors 
No information was provided about typing, clonality or virulence factors of respiratory 
pathogens causing CAP in Southeast Asia. 
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MANAGEMENT OF PATIENTS 
 
Quality of care 
As the burden of illness caused by CAP is high, clinicians should strive to deliver the 
highest quality of care to the patients [63]. Several guidelines have been developed to 
improve the outcomes for CAP patients. These guidelines are expected to reduce the 
variation in key aspects of care and to improve the efficacy and effectiveness of health 
care [59,64]. In many countries, key recommendations from the guidelines are translated 
into the so-called quality indicators, by which the quality of care provided to the patients 
can be measured and assessed [59]. Examples of quality indicators for the care of CAP 
patients are initiating antibiotics  within 4 hours after presentation, prescribing antibiotics 
according to national guidelines, changing broad-spectrum empirical therapy to pathogen-
directed therapy as soon as culture results become available [59,63] and collection of 
blood cultures before antibiotic therapy is started [63]. The development of quality 
indicators for CAP patient care is underlined since CAP is common, costly, and responsible 
for a large burden of morbidity and mortality  in many countries of the world including 
Southeast Asia [1], and there is link between process of care measures and patient 
outcome [65]. We found no information about the assessment of quality of care in CAP 
patients in the papers from Southeast Asia. 
 
Antibiotic treatment 
Antibiotic treatment is one of the most important therapeutic measures in CAP patients. In 
the reviewed papers not much attention was paid to treatment. A study from Singapore 
[34] reported that third generation cephalosporins were most frequently prescribed for 
severe episodes of CAP (43% out of 44 patients), while in Malaysia, 62% of hospitalised CAP 
patients were treated with a combination of a β-lactam antibiotic (amoxicillin/clavulanate, 
ampicillin/sulbactam, ceftriaxone, cefuroxime, ceftazidime or penicillin) and a macrolide 
(erythromycin or azithromycin) [49].  
A  clinical trial to study the benefit of adding a macrolide to broad-spectrum 
antibiotics ampicillin/sulbactam, amoxicillin/ clavulanic acid,  cefuroxime, cefepime, 
cefotaxime, ceftriaxone, ciprofloxacin) was performed in Malaysia showing that the 
addition of a macrolide did not benefit patients in terms of mortality, requirement for 
mechanical ventilation and length of hospital stay [35]. In this study, the isolated 
pathogens were K. pneumoniae (17.6%), Acinetobacter spp. (3.4 %), Pseudomonas spp. 
(3.4 %) and Enterobacter spp. (0.8%), however, microbiological methods were poorly 
described, and no tests to detect atypical pneumonia agents were applied.  
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OUTCOME 
 
Outcome of patients were reported as improvement, complications, length of stay, and 
survival and mortality rate. 
 
Clinical improvement 
A Thai study reported that clinical improvement was achieved in 91% of out-patients within 
6.4 days on average (SD 2.2) [42]. From the same Thai hospital clinical improvement was 
reported in 84% of hospitalized CAP patients, an average  length of stay of 12.9 ±14 (SD) 
days, and a mortality rate of 6%. In CAP patients cared for in the ICU improvement was 62% 
within 15 days on average (SD 14.3) and the mortality rate 21%. None of the studies 
reported à priori defined  clinical improvement. 
 
Complications  
The most common complications seen in patients with CAP were acute respiratory failure 
(31%), septic shock (21%), parapneumonic effusions or pleural empyema (13%) [43]. 
Patients with severe CAP had the highest rates of complications: respiratory failure 82%, 
septic shock 57%  and acute renal failure 12% [66]. The incidence of septic shock was 
highest when the etiology was S. aureus (33.3%) and B. pseudomallei (30%), and lowest 
when it was  M. pneumoniae (12.5%). Respiratory failure happened most frequently when 
the etiology was S. aureus, B. pseudomallei and H. influenzae (47.5-50%) [47]. Patients aged 
>65 years developed respiratory failure and hypotension more frequently (48%) than those 
<65 year (13.3%), but no differences in the occurence of disseminated intravascular 
coagulation and pleural effusion with regard to patients’ age were reported [33]. Other 
complications were hospital-acquired pneumonia (HAP), pneumothorax, empyema thorax, 
and extrapulmonary infection  [43,44,47].  
 
Length of stay 
The median length of stay ranged from 3-5 days in young patients [33] to 15 days in older 
patients [44]. Longer length of stay  was  in general associated with severity of 
pneumonia, dysphagia, chronic renal disease, hypo-albuminemia, and elderly age. In 
younger patients (aged <65 years), hypo-albuminemia was associated with a longer length 
of stay, while in elderly patients, longer length of stay was associated with severity of the 
disease, dysphagia, and type of residence [33].  
 
 
40 Chapter 244 |Community-acquired pneumonia in adults in Southeast Asia 
 
  
Mortality 
All papers reported mortality as in-hospital mortality, rather than 30-day mortality. 
Overall mortality among hospitalised CAP patients ranged 1.2-5.9% [39] to 24% 
[24,32,33,35,37,38,45,51]. Mortality  was consistently associated with severity of 
pneumonia calculated with any scoring method [32-34,38,43,44]. Male sex [38], age >65 
years [33], dysphagia [33], blood urea >7 mmol/L [50], multilobar involvement [50], 
hypoxemia (PaO2 <8kPa) or decreased SpO2 >5% [38,50], multiple or important 
comorbids [33], hypo-albuminemia [33], delayed admission to ICU [34], PSI score IV-V at 
admission [34], the presence of three or more minor criteria of the IDSA/ATS guideline 
[34] were found to increase mortality as independent risk factors. HIV positive state [36], 
infection by GNB, in particular B. pseudomallei or by S. aureus also led to higher mortality 
[45,47].  
 
 
DISCUSSION 
 
Despite the significant burden on the health care system and the high level of morbidity 
and mortality associated with CAP, there is still a paucity of research on CAP in Southeast 
Asia. Information about the incidence of CAP was available only from Thailand [31,36,53]. 
The incidence rate depended on whether passive or active surveillance was used. With 
active surveillance the incidence was about 3 times higher than with passive surveillance, 
580 to 831/ 100,000 population (including children) vs 236/100,000 population (including 
children), respectively.  For comparison, the incidence of CAP requiring hospital admission 
in the United States of America (USA)  was 266/100,000 for the adult population ranging 
91.6/100,000 in those <45 year-old to 1,012/100,000 in those >65 year-old [60], in the 
United Kingdom (UK) 198/100,000 adult population [67]. However, not all of the incidence 
rates of CAP reported in this review were comparable because of differences in the 
method of data collection (active vs passive surveillance), the method of calculation 
(hospitalized CAP  vs hospitalized CAP adjusted for health care seeking behavior), and in 
age grouping. Accurate data of the incidence of CAP are scarce. Although pneumonia is a 
reportable disease in many countries, reports might not be directly comparable  because 
of differences in terminology, method of epidemiology study, and the proportions of the 
pneumonia prone age population in the country. The paucity of published data on CAP 
incidence among adults in the Asia-Pacific region,  differences in cultures and climates and 
the wide variation in reported incidence underscore the need for surveillance studies. In 
addition, as the percentages of elderly people in the population are estimated to double 
during 2010-2050 world wide [68], the importance of preventing CAP in elderly will be 
more striking. Uniformity in the calculation and reporting is important for comparison of 
the study results between countries. 
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Seasonal variation was found for overall incidence of CAP and for incidence of specific 
pathogens [36,39]. In Thailand, CAP incidence peaked twice per year: January-March and 
August-October [36,39]. In both peaks influenza virus was the predominant pathogen; in 
the second peak (August-October) accompanied by a much broader range of other viruses 
than in the January-March period. The atypical pathogens peaked in October-November. 
A study from Malaysia  in 2013 reported that  RSV, parainfluenza, influenza, and 
adenovirus caused respiratory infection among children throughout the year, with a 
seasonal peak observed for RSV in September-December. Monthly RSV cases were directly 
correlated with rain days, and inversely correlated with relative humidity and temperature 
[69].  A review on seasonality of CAP  from international studies, in particular from 
northern earth hemisphere, showed distinct seasonal patterns in the occurrence of CAP: 
34% of CAP admissions occurred in spring; 18% in autumn; 26% in winter; and 22% in 
summer (p = 0.036) [70]. Another review found that both latitude and hemispheres affect 
the incidence of influenza virus and RSV infection [71]. The incidence of influenza viruses 
infection peaked during winter in both temperate northern and southern hemispheres, 
and during March to May in tropical southern hemisphere. However, in tropical northern 
hemisphere, the influenza infections occured throughout the year with no peak. RSV 
infections also peaked during winter in both temperate northern and southern 
hemispheres, while in both tropical northern and southern, the incidence accured 
throughout the year with no peak [71].  Because the alteration and nature of seasons 
depends very much on where you are on earth, information of seasonality is only 
meaningful for the geographical area from where the information was obtained. 
Therefore, the topic of seasonality deserves more attention in Southeast Asian countries. 
Such information will help to guide and evaluate prevention strategies [31].  
Usually CAP presented itself with alveolar abnormalities on the X-rays, although there 
was a wide range of frequency between the studies. Second came interstitial 
abnormalities and less frequently combinations of alveolar and interstitial abnormalities 
were described. A relationship between radiological image and etiology was found for 
atypical pneumonias in children [41] and for tuberculosis [49,50], but not for other 
etiologies, particularly not in adults. 
The occurrence of severe CAP ranged from 17-50%, for an important part depending 
on the definition used for severity. Older age and underlying diseases predisposed for 
severe CAP. A relationship between severity and etiology was not found, but investigated 
in only one study.   
A number of studies investigated the pathogens that cause CAP in Southeast Asian 
countries. A problem with the interpretation of the results of those studies is that often 
the methods are poorly described, that there are differences between the methods used, 
that there are differences in interpretation of the test results and that in many studies 
only a limited range of tests were used, for instance, only bacterial diagnostics, only tests 
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for atypical bacteria or some other specific pathogens. The incompleteness of the 
investigations was reflected in the wide range (5-74%) of patients in whom the etiology 
was unidentified. A single pathogen was found on average 33% of the patients, range 9-
65%, and a mixed infection (infection by >1 pathogen), on average 7%, range 0-17%.  
The most frequent diagnoses were infections due to K. pneumoniae (9.5%), S. 
pneumoniae (9.2%) and  C. pneumoniae (8.4%). Infections with involvement of GNB other 
than K. pneumoniae and B. pseudomallei came in fourth (7.4%). Taken together, all GNB 
accounted for 21%  of the agents causing CAP. This predominance of GNB is very different 
from that in developed countries in which S. pneumoniae is consistently the most 
common etiology [72-74]. The tropical climate with higher temperature and humidity in 
Southeast Asia may increase the incidence of GNB infection, as those conditions promote 
the growth and virulence of GNB [75,76]. However, further etiological studies are needed 
using better standardized laboratory tests and interpretation methods. 
Mixed infections involving 2-4 pathogens were quite frequently reported. Some of the 
reported mixed infections had a familiar pattern: viral infection with superimposed 
bacterial infection and tuberculosis with superimposed infection. The pathogenesis of 
other mixed infections  with multiple bacteria or multiple viruses,  or with bacteria and 
fungi are more difficult to understand, posing the problem of discriminating between 
infection and carriage, and questioning each isolate’s role in the pathogenesis of the 
specific case of CAP. Therefore, specific methods should be implemented to reduce the 
chance of reporting simple upper respiratory tract colonization as true infection. Accurate 
information about etiology helps the development of more appropriate local guidelines 
for the management of CAP, and helps to select which diagnostic facilities, promotive and 
preventive measures should be prioritized. 
The magnitude of the antimicrobial resistance problem among CAP causing pathogens 
in Southeast Asia was difficult to assess. Few data are available and the methods used 
were not comparable either because of incomplete description, or the use of non-
standardized methods. Microbiology laboratories should be encouraged to perform the 
antimicrobial susceptibility tests according to standardized methods including the use of 
control strains. With such limited data on antimicrobial resistance of pathogens causing 
CAP available, there is at the moment no priority to study clonality. 
Patients who were treated for CAP as outpatients, have the highest rate of recovery on 
average, the shortest duration of illness and the lowest rate of complications, whereas the 
reverse applied to patients with severe CAP. Overall mortality in patients hospitalized for 
CAP can be low (1.2%), but can increase to about a quarter of the patients. In patients 
with severe CAP and patients over 65 years old the highest rates of mortality were 
observed, up to over 50%. These rates were much higher than those reported in another 
study from Asia [77]. Many determinants for death due to CAP have been described in 
patients from Southeast Asia, the most important being severity of disease, older age and 
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multilobar involvement of the lungs. However, the quality of care, as a contributor of 
patient recovery could not be assessed because such reports were not found in the 
review. 
Some of the independent risk factors for mortality have also been found in studies 
from other parts of the world, including expansion of infiltrates [78-80], elderly age 
[79,81], severe renal dysfunction [67,82], hypoxemia [83], and GNB etiology [84]. Other 
studies reported other independent risk factors such as  cardiovascular disease [81,84], 
altered mental status [78-80],, hyperglycaemia [82,85],  cerebrovascular disease [81],  
hyponatraemia [84,86],  respiratory rate >30 breaths per minute [80,83], circulatory shock 
[80,83] and need for ICU admission or mechanical ventilation on admission [79,86]. Such 
differerence in the identification of risk factors for mortality might relate to the 
population characteristics, or the specific researcher’s intentions of the study. 
The high mortality rates from CAP in Southeast Asia should increase the clinicial 
awareness in identifying patients at higher risk for mortality and optimizing measures to 
prevent death. Studies on risk factors for mortality, antibiotic therapy and other specific 
therapeutic measures, and on the quality of patient care are urgently needed. Not less 
important are studies on the prevention of CAP, such as promoting vaccination and 
smoking cessation, which were not found in our review. 
 
CONCLUSION AND FINAL REMARKS 
 
Studies for community-acquired pneumonia in Southeast Asia are still very limited while 
this disease remains a significant cause of morbidity and mortality, and has a high 
economical burden. Some of selected studies also had methodological limitations that 
precluded the possibility to draw conclusions and the applicability in clinical practice. For 
better understanding of CAP in Southeast Asia, more and better standardized studies are 
required on the etiology, management, and quality of care. 
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ABSTRACT  
 
Background 
Knowledge about the etiology of community-acquired pneumonia (CAP) is essential for 
adequate management. Presently, only few studies about CAP are available from 
Southeast Asia.  
Method 
From October 2007 to April 2009, adult patients admitted with CAP to two hospitals in 
Semarang, Indonesia, were included in our study to detect the bacterial and viral etiology 
using a wide range of advanced diagnostic methods. The severity of disease  was classified 
according to the Pneumonia Severity Index (PSI) and the outcome was assessed as 30-day 
mortality. 
Results 
In total, 148 patients were included. Influenza virus (18%), Klebsiella pneumoniae (14%), 
and Streptococcus pneumoniae (13%) were the most common agents. Mixed infections 
were common (28%). Other Gram-negative bacilli, Mycobacterium tuberculosis, 
Chlamydia pneumoniae each accounted 5%. The bacteria presented wild type antibiotic 
susceptibility profiles. Forty-four percent of included subjects were high-risk patients (PSI 
class IV-V), and 52% had at least one underlying disease. The mortality rate (30%) was 
significantly associated with severity (P<0.001), and with failure to establish an etiological 
diagnosis (P=0.027). No associations were found between etiology and underlying 
diseases, PSI class, nor mortality (P >0.05).  
Conclusions 
Viruses and Gram-negative bacilli are dominant causes of CAP in this region, more so than 
S. pneumoniae. Most of the bacteria have wild type susceptibility to antimicrobial agents. 
Patients with severe disease and those with unknown etiology had higher mortality. 
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INTRODUCTION 
 
Knowledge about the etiology of community-acquired pneumonia (CAP) is essential for 
patient management [1]. However, only few studies on CAP are available from Southeast 
Asia; and most used  limited microbiological methods [2-5]. This study aimed to describe 
the current etiology of CAP using full-range diagnostic methods, antimicrobial 
susceptibility, underlying diseases, severity and outcome of CAP patients in Indonesia.  
 
 
MATERIAL AND METHOD 
 
Study design  
A prospective cohort study was performed in Dr. Kariadi Hospital (an 850-bed academic 
hospital) and in Semarang Municipal Hospital (a 130-bed secondary hospital). 
 
Subjects 
From October 2007 until April 2009 hospitalised patients >13 years were included if CAP 
was diagnosed within 24 hours of admission. CAP was defined as radiological evidence of 
an infiltrate on chest X-ray and >2 of 6 criteria (cough, purulent sputum, temperature 
>38.50C, abnormal chest auscultation, white blood cells >10 or <4 x 109/l, positive culture 
of blood or pleural fluid). Subjects were excluded if they had received parenteral antibiotic 
before inclusion, had been hospitalised within four weeks of admission, were severely 
immunocompromised (HIV infection, chemotherapy, neutropenia <1000/uL, steroid 
treatment >20mg/day for more than two weeks), had terminal stage of malignancy, or 
evidence of other causes of abnormalities on the X-ray. Subjects with missing data of  30-
day mortality were excluded for the analysis for mortality but not for the etiology, severity 
and underlying diseases. 
 
Data collection 
All patients were assessed upon admission, followed daily during hospitalisation, and on 
day-30 according to a standardised protocol. Age, gender, cigarette and alcohol use, and 
clinical presentations were recorded. The admission chest X-rays were assessed by a 
radiologist in-charge, and later re-assessed to develop standardised X-ray descriptions. 
Complete blood cell-count, blood chemistry, and blood-gas analysis were performed on 
admission. Underlying diseases were assessed from clinical, laboratory and radiology data. 
Severity score was determined using the Pneumonia Severity Index (PSI) [6]. The outcome 
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was assessed as 30-day mortality. Management of patients was leaved to the discretion of 
the physicians in charge.  
 
The microbiological evaluation 
Sputum, throat swab, blood, paired sera with a 4-week interval, and urine were sent to 
Clinical Microbiology Laboratory of Dr. Kariadi Hospital, Semarang. Gram-stained smears 
were evaluated to assess sputum quality and to help culture interpretation. Ziehl–Neelsen 
staining was done to screen for acid fast bacilli. Sputum and blood cultures (four BACTEC 
bottles [Becton-Dickinson, Rochester, UK] per patient) were performed on blood agar, 
chocolate agar, chocolate agar with gentamicin 5mg/L, and MacConkey agar (Oxoid, 
Basingstoke, UK). Crystal violet colistine broth (CVCB) and Ashdown agar [7] were used for 
Burkholderia pseudomallei isolation. Bacteria isolated from the initial cultures, sputa, 
throat swabs, sera, and urine were stored at -80oC, and transported to Rotterdam, for 
further analyses.  
Streptococcus pneumoniae was identified with optochin disk (Oxoid) and, in case of 
doubt, DNA probe (Accuprobe, San Diego, USA). Gram-negative bacilli (GNB) were 
identified using the Vitek-2 system (bioMérieux, l’Etoile, France). Acinetobacter baumannii 
was identified using PCR (blaOXA-51-like) [8]. Moraxella catarrhalis was confirmed using 
tributyrin test (Rosco Diagnostics-Taastrup, Denmark). X-V factors (Becton, Dickinson and 
Company - Sparks, USA) were used for Haemophilus influenzae identification. Slidex Staph 
Plus latex agglutination (bioMérieux) and Vitek-2 were used for Staphylococcus aureus 
identification. Ziehl-Neelsen positive sputa were cultured on MGIT media (Becton-
Dickinson, Rochester, UK) and proceeded to PCR. Antimicrobial susceptibility tests were 
performed with disk diffusions (for S. pneumoniae), Vitek-2 (for S. aureus and GNB), and E-
test (for M. catarrhalis). When extended-spectrum β-lactamase (ESBL)-production was 
suspected, isolates were further analyzed with with cefotaxime-clavulanate or 
ceftazidime-clavulanate E-test (bioMérieux). Reference strains from ATCC were used as 
controls and CLSI guidelines were applied.   
Serology tests were performed with ELISA for Chlamydia pneumoniae  (Medac 
Diagnostika, Germany), Mycoplasma pneumoniae (Virion\Serion, Würzburg, Germany), 
and Legionella pneumophila (Wampole Laboratories, Princeton, USA). Leptospira serology 
was performed using microscopic agglutination test (MAT) and ELISA [9] in the Royal 
Tropical Institute (KIT), Amsterdam, the Netherlands, if the patient had a clinical syndrom 
of leptospirosis. ELISA for respiratory viruses (Virion\Serion) was performed in the 
Laboratory of Virology, Erasmus MC. Real- time PCRs (RT-PCRs) were done on sputa and 
throat swabs for C. pneumoniae and L. pneumophila as described elsewhere [10].  RT-PCR 
for M.  pneumoniae, rhinovirus, human corona virus (HcoV) 229E, OC43, and NL63, 
influenza A and B virus, human metapneumovirus (hMPV), RSV A and B, parainfluenza 1- 4 
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virus, adenovirus, and bocavirus were performed on throat swabs. Validation of PCR 
procedures was described before [11,12]. PCR for Leptospira and for Chlamydia psittaci 
were done as described elsewhere [13,14]. PCR for Mycobacterium tuberculosis was 
performed in Erasmus MC. Urinary antigen tests (BinaxNOW, Portland, USA) were 
performed to detect S. pneumoniae and L. pneumophila serogroup-1 antigen. 
 
Diagnostic criteria for microbial etiological agents 
Sputum cultures were considered positive if sputum quality was good (leukocytes: 
epithelial-cells ratio was >2.5: 1, leukocyte count was >10/low power field (LPF), 
epithelial-cell count was <10/LPF), and bacteria growing predominantly on agar were 
compatible with sputum microscopy. Blood cultures were considered positive if bacteria 
presented in ≥1 bottle for established pathogens or ≥2 bottles for potential skin 
contaminants.  
Serology was considered positive if there was a four-fold titer increase of any 
immunoglobulin class. For influenza A and B, since re-infection in one year is unlikely, 
single sera with positive IgA and negative IgG during the first week of illness were also 
considered positive. Immunoglobulin classes measured were IgM, IgA, and IgG for C. 
pneumoniae; total immunoglobulin for L. pneumophila; IgA and IgG for respiratory viruses; 
IgM and IgG for M. pneumoniae; IgM and total immunogloblin for Leptospira.  
RT-PCR were considered positive if the CT value was <50 for M. pneumoniae, <35 for 
Leptospira, and <40 for other pathogens. A positive influenza A PCR was followed with 
another PCR to distinguish H5N1 from other influenza A viruses. Any positive reaction of 
the urinary antigen tests was considered positive. 
A comprehensive review on clinical, radiology, and laboratory data was performed by 
panel discussions involving a pulmonologist, infectious disease specialists, radiologists, 
and clinical microbiologists to draw the final conclusions on the etiology of CAP. Etiology 
was considered if microbiology test results were compatible with the clinical presentation 
and radiology.  
 
Statistical analyses 
Chi-Square or Fisher’s exact test where appropriate was performed using SPSS 17 (SPSS 
Inc., Chicago, USA). The Kaplan-Meier method and the log-rank test were used to perform 
survival analysis. P value of <0.05 was considered significant. 
 
Ethics 
The study was approved by The Ethical Committee of Faculty of Medicine Diponegoro 
University- Dr. Kariadi Hospital (36EC/FK/RSDK/2007). A written informed consent was 
obtained from each patient or guardian. 
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RESULTS 
 
Patient characteristics 
Of the 156 patients enrolled; 135 were hospitalised in Dr. Kariadi hospital and 21 in 
Semarang Municipal hospital. Eight patients were excluded because of non-confirmed CAP 
diagnosis (acute respiratory distress syndrome (3 patients), urosepsis (2 patients), no 
infiltrate on the X-ray on re-assessment (2 patients)), or preceding parenteral antibiotics 
(1 patient)). No 30-day mortality data was missing.  
 
Table 1. Characteristics of patients with community-acquired pneumonia in Semarang, Indonesia 
Characteristic Number (%) of Patients, 
   N=148 
Age years, median; Inter quartile range (IQR) 58; 45-69 
Male/female 73 (49) / 75 (51) 
Length of stay, median; IQR days  6; 4-8 
30-day  mortality  44 (30) 
Underlying diseases   
 Hypertension  25  (17) 
 Congestive heart disease 16  (11) 
 Diabetes mellitus 14  (10) 
 Chronic obstructive pulmonary disease  12    (8) 
 Stroke  27  (18) 
 Asthma    3   (2) 
 Malignancy    5   (3) 
 Chronic kidney disease    4   (3) 
Pneumonia Severity Index (PSI) *  
 Class I    6   (4) 
 Class II  45  (30)  
 Class III  32  (22) 
 Class IV  45  (30) 
 Class V  20  (14) 
Chest X-ray   
 Bronchopneumonia 103  (70) 
 Alveolar pneumonia 32  (21) 
 Interstitial pneumonia 13    (9) 
Specimens obtained   
 Sputum, total/good quality** 103 (70) / 57 (39) 
 Blood culture  148 (100) 
 Paired sera/single sera 83 (56)  / 64 (43) 
 Throat swabs 148 (100) 
 Urine 145 (98) 
* according to Fine et al, 1997 [6] 
** sputum was considered of good quality if the leukocytes : epithelial cells ratio was >2.5, the leukocyte count 
was  >10/LPF and the epithelial cell count <10/LPF 
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Patients’ ages ranged 14–88 years, with 32% aged  >60 years. Most patients (52%) had 
underlying diseases, with 19% having two or more underlying diseases. Severe pneumonia 
(PSI IV-V) was found in 44% patients. Most (70%) of the chest X-rays showed 
bronchopneumonia (Table 1). 
Only 15% of patients had not received oral antibiotics prior to hospital admission, 
while 50% were unsure whether they had received antibiotics or not. Thirty eight (26%) 
patients had a complete set of test specimens (Table 1). No data were missing for 
underlying diseases, severity, and 30-day mortality. 
 
Microbiological results 
One-hundred and fifty respiratory pathogens were identified from 100 (68%) patients. The 
microbiological methods by which pathogens were identified are described in Table 2. Final 
conclusions regarding the CAP etiology are summarised in Tables 3 and 4. 
A single causative agent was found in 58 (39%) patients, of which 33 (22%) were viruses and 25 
(17%) were bacteria. Polymicrobial infection was found in 42 (28%) patients, including viral 
infections with superimposed bacterial infection, tuberculosis with superimposed secondary 
infection, and other mixed-infections (multiple viruses, multiple bacteria, and combinations of 
virus(es) and bacteria) (Table 3).  
Seventy viruses were identified in 67 (45%) patients, with influenza A as commonest, identified 
in 20 (13.5%) patients. PCR detected 16 (80%) cases, while serology detected 10 (50%) cases (Table 
2). All influenza A viruses were H3N2. In 12 patients it was the single pathogen found (Table 3); in 
eight patients other pathogens were also involved (Table 4). Together, influenza A and B viruses 
caused 26 (18%) CAP in our patients either as single or as co-pathogen.  
The second commonest virus was rhinovirus, which in all 13 (9%) cases were detected by PCR. In 
six patients this virus was the single pathogen; in seven it was a co-pathogen. Parainfluenza virus 
was the third commonest virus, detected in 11 (7%) patients, mostly by PCR; five episodes as single 
pathogen and six as co-pathogen. Other viruses found were HcoV OC43, adenovirus, hMPV, and 
RSV; most were as co-pathogens, and detected by PCR. 
Eighty bacteria were found in 65 (44%) patients, with Klebsiella pneumoniae and S. pneumoniae 
as the most frequently diagnosed. K. pneumoniae was isolated from 21 (14%) patients; most (95%) 
from sputum cultures, and 5% from both blood and sputum cultures. S. pneumoniae was diagnosed 
in 20 (13%) patients; most (75%) by urinary antigen tests (Table 2). C. pneumoniae and M. 
tuberculosis were the third commonest bacterial species identified; each was diagnosed in 5% of 
patients. Other GNB (Enterobacter cloacae, Klebsiella oxytoca, Achromobacter xylosoxidans, and 
Burkholderia cepacia) were identified in 7 (5%) patients; most were isolated from sputum cultures. 
No Burkholderia pseudomallei was found. Blood cultures were positive only in 4 (2%) patients. 
Combinations of pathogens in 42 patients are presented in Table 4. Frequent combinations of 
pathogens were K. pneumoniae + S. pneumoniae (n=5), adenovirus + K. pneumoniae (n=4), and 
influenza or coronavirus + S. pneumoniae (n=3 each). 
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Patients’ ages ranged 14–88 years, with 32% aged  >60 years. Most patients (52%) had 
underlying diseases, with 19% having two or more underlying diseases. Severe pneumonia 
(PSI IV-V) was found in 44% patients. Most (70%) of the chest X-rays showed 
bronchopneumonia (Table 1). 
Only 15% of patients had not received oral antibiotics prior to hospital admission, 
while 50% were unsure whether they had received antibiotics or not. Thirty eight (26%) 
patients had a complete set of test specimens (Table 1). No data were missing for 
underlying diseases, severity, and 30-day mortality. 
 
Microbiological results 
One-hundred and fifty respiratory pathogens were identified from 100 (68%) patients. The 
microbiological methods by which pathogens were identified are described in Table 2. 
Final conclusions regarding the CAP etiology are summarised in Tables 3 and 4. 
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viruses and 25 (17%) were bacteria. Polymicrobial infection was found in 42 (28%) 
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superimposed secondary infection, and other mixed-infections (multiple viruses, multiple 
bacteria, and combinations of virus(es) and bacteria) (Table 3).  
Seventy viruses were identified in 67 (45%) patients, with influenza A as commonest, 
identified in 20 (13.5%) patients. PCR detected 16 (80%) cases, while serology detected 10 
(50%) cases (Table 2). All influenza A viruses were H3N2. In 12 patients it was the single 
pathogen found (Table 3); in eight patients other pathogens were also involved (Table 4). 
Together, influenza A and B viruses caused 26 (18%) CAP in our patients either as single or 
as co-pathogen.  
The second commonest virus was rhinovirus, which in all 13 (9%) cases were detected 
by PCR. In six patients this virus was the single pathogen; in seven it was a co-pathogen. 
Parainfluenza virus was the third commonest virus, detected in 11 (7%) patients, mostly 
by PCR; five episodes as single pathogen and six as co-pathogen. Other viruses found were 
HcoV OC43, adenovirus, hMPV, and RSV; most were as co-pathogens, and detected by PCR. 
Eighty bacteria were found in 65 (44%) patients, with Klebsiella pneumoniae and S. 
pneumoniae as the most frequently diagnosed. K. pneumoniae was isolated from 21 (14%) 
patients; most (95%) from sputum cultures, and 5% from both blood and sputum cultures. 
S. pneumoniae was diagnosed in 20 (13%) patients; most (75%) by urinary antigen tests 
(Table 2). C. pneumoniae and M. tuberculosis were the third commonest bacterial species 
identified; each was diagnosed in 5% of patients. Other GNB (Enterobacter cloacae, 
Klebsiella oxytoca, Achromobacter xylosoxidans, and Burkholderia cepacia) were identified 
in 7 (5%) patients; most were isolated from sputum cultures. No Burkholderia 
pseudomallei was found. Blood cultures were positive only in 4 (2%) patients. 
58 Chapter 3
58
 | 
Et
io
lo
gy
 o
f c
om
m
un
ity
-a
cq
ui
re
d 
pn
eu
m
on
ia
 in
 In
do
ne
sia
 
  Ta
bl
e 
2.
 P
at
ho
ge
ns
 is
ol
at
ed
 fr
om
 la
bo
ra
to
ry
 sp
ec
im
en
s o
bt
ai
ne
d 
fr
om
 p
at
ie
nt
s w
ith
 c
om
m
un
ity
-a
cq
ui
re
d 
pn
eu
m
on
ia
 in
 S
em
ar
an
g,
 In
do
ne
sia
 
   P
at
h
o
g
en
s 
Blood Culture 
Sputum Culture 
Urinary Antigen 
Test 
Blood + Sputum 
Culture 
Sputum Culture + 
UAT 
Blood and Sputum 
Culture  +  UAT 
Serology 
PCR 
Serology + PCR 
Culture  + PCR 
Total 
V
ir
u
se
s 
 
 
 
 
 
 
 
 
 
 
 
 
Inf
lue
nz
a A
 vi
ru
s 
 
 
 
 
 
 
  4
 
10
 
6 
 
20
 
 
Inf
lue
nz
a B
 vi
ru
s 
 
 
 
 
 
 
  2
 
  4
 
 
 
  6
 
 
Rh
ino
vir
us
 
 
 
 
 
 
 
  
13
 
 
 
13
 
 
PI
V 
1-
4  
 
 
 
 
 
 
  2
 
  9
 
 
 
11
 
 
Hc
oV
  O
C4
3 
 
 
 
 
 
 
 
  8
 
 
 
  8
 
 
Ad
en
ov
iru
s 
 
 
 
 
 
 
  2
 
  4
 
 
 
  6
 
 
hM
PV
 
 
 
 
 
 
 
 
  4
 
 
 
  4
 
 
RS
V 
 
 
 
 
 
 
  1
 
  1
 
 
 
  2
 
T
o
ta
l V
ir
u
se
s 
 
 
 
 
 
 
11
 
53
 
6 
 
70
 
 
 
 
 
 
 
 
 
 
 
 
 
B
ac
te
ri
a 
 
 
 
 
 
 
 
 
 
 
 
 
S
. p
ne
um
on
ia
e 
 
 
  1
 
15
 
 
3 
1 
 
 
 
 
20
 
 
S
. a
ur
eu
s 
 
  3
 
 
1 
 
 
 
 
 
 
  4
 
 
K
. p
ne
um
on
ia
e 
 
20
 
 
1 
 
 
 
 
 
 
21
 
  
Ot
he
r G
NB
 
1 
  6
 
 
 
 
 
 
 
 
 
  7
 
 
M
. c
at
ar
rh
al
is
 
 
  5
 
 
 
 
 
 
 
 
 
  5
 
59Etiology of community-acquired pneumonia in Indonesia
Et
io
lo
gy
 o
f c
om
m
un
ity
-a
cq
ui
re
d 
pn
eu
m
on
ia
 in
 In
do
ne
sia
 
59
 
  
 
 
 
 
 
 
 
 
 
 
 
 
   P
at
h
o
g
en
s 
Blood Culture 
Sputum Culture 
Urinary Antigen 
Test 
Blood + Sputum 
Culture 
Sputum Culture + 
UAT 
Blood and Sputum 
Culture  +  UAT 
Serology 
PCR 
Serology + PCR 
Culture  + PCR 
Total 
 
C
. p
ne
um
on
ia
e 
 
 
 
 
 
 
  8
 
 
 
 
  8
 
 
M
. p
ne
um
on
ia
e 
 
 
 
 
 
 
 
 
1 
 
 
  1
 
 
L.
 p
ne
um
op
hi
la
 
 
 
  1
 
 
 
 
 
 
 
 
  1
 
 
M
. t
ub
er
cu
lo
si
s 
 
 1
 
 
 
 
 
 
 
 
7 
  8
 
 
Le
pt
os
pi
ra
 
 
 
 
 
 
 
1 
2 
2 
 
  5
 
T
o
ta
l b
ac
te
ri
a 
1 
36
 
16
 
2 
3 
1 
9 
3 
2 
7 
80
 
T
o
ta
l p
at
h
o
g
en
s 
 
 
 
 
 
 
 
 
 
 
15
0 
 U
AT
 =
 u
rin
ar
y 
an
tig
en
 te
st
,  
PI
V 
= 
pa
ra
in
flu
en
za
 v
iru
s,
  H
co
V=
 h
um
an
 c
or
on
av
iru
s,
 h
M
PV
 =
 h
um
an
 m
et
ap
ne
um
ov
iru
s,
  
RS
V 
= 
re
sp
ira
to
ry
 sy
nc
yt
ia
l v
iru
s 
 O
th
er
 G
N
B 
= 
O
th
er
 G
ra
m
-n
eg
at
iv
e 
ba
ci
lli
, i
.e
. E
. c
lo
ac
ae
, S
. m
al
to
ph
ili
a,
 A
.  
xy
lo
so
xi
da
ns
, B
. c
ep
ac
ia
 
58
 | 
Et
io
lo
gy
 o
f c
om
m
un
ity
-a
cq
ui
re
d 
pn
eu
m
on
ia
 in
 In
do
ne
sia
 
  Ta
bl
e 
2.
 P
at
ho
ge
ns
 is
ol
at
ed
 fr
om
 la
bo
ra
to
ry
 sp
ec
im
en
s o
bt
ai
ne
d 
fr
om
 p
at
ie
nt
s w
ith
 c
om
m
un
ity
-a
cq
ui
re
d 
pn
eu
m
on
ia
 in
 S
em
ar
an
g,
 In
do
ne
sia
 
   P
at
h
o
g
en
s 
Blod Culture 
Sputum Clture 
Urinary Antigen 
Test 
Blod + Sptum 
Culture 
Sputum Clture + 
UAT 
Blod and Sputum 
Culture  +  UAT 
Serology 
PCR 
Serology + PCR 
Culture  + PCR 
Total 
V
ir
u
se
s 
 
 
 
 
 
 
 
 
 
 
 
 
Inf
lue
nz
a A
 vi
ru
s 
 
 
 
 
 
 
  4
 
10
 
6 
 
20
 
 
Inf
lue
nz
a B
 vi
ru
s 
 
 
 
 
 
 
  2
 
  4
 
 
 
  6
 
 
Rh
ino
vir
us
 
 
 
 
 
 
 
  
13
 
 
 
13
 
 
PI
V 
1-
4  
 
 
 
 
 
 
  2
 
  9
 
 
 
11
 
 
Hc
oV
  O
C4
3 
 
 
 
 
 
 
 
  8
 
 
 
  8
 
 
Ad
en
ov
iru
s 
 
 
 
 
 
 
  2
 
  4
 
 
 
  6
 
 
hM
PV
 
 
 
 
 
 
 
 
  4
 
 
 
  4
 
 
RS
V 
 
 
 
 
 
 
  1
 
  1
 
 
 
  2
 
T
o
ta
l V
ir
u
se
s 
 
 
 
 
 
 
11
 
53
 
6 
 
70
 
 
 
 
 
 
 
 
 
 
 
 
 
B
ac
te
ri
a 
 
 
 
 
 
 
 
 
 
 
 
 
S
. p
ne
um
on
ia
e 
 
 
  1
 
15
 
 
3 
1 
 
 
 
 
20
 
 
S
. a
ur
eu
s 
 
  3
 
 
1 
 
 
 
 
 
 
  4
 
 
K
. p
ne
um
on
ia
e 
 
20
 
 
1 
 
 
 
 
 
 
21
 
  
Ot
he
r G
NB
 
1 
  6
 
 
 
 
 
 
 
 
 
  7
 
 
M
. c
at
ar
rh
al
is
 
 
  5
 
 
 
 
 
 
 
 
 
  5
 
60 Chapter 360 | Etiology of community-acquired pneumonia in Indonesia 
 
  
Table 3. Final etiological diagnosis in patients presenting with community-acquired pneumonia in 
Semarang, Indonesia 
Etiology Patients (N =148) 
Number (%) 
Single pathogen 58 (39) 
      virus   
 Influenza A/B 12  (8) / 5 (3) 
 Rhinovirus   6  (4) 
 Parainfluenza virus   5  (3) 
 Adenovirus   2  (1) 
 RSV   1  (1) 
 Coronavirus OC43   1  (1) 
 human Metapneumovirus   1  (1) 
  Subtotal  33 (22) 
          bacteria   
 K. pneumoniae 5  (3) 
 S. pneumoniae 5  (3) 
 M. tuberculosis 5  (3) 
 Leptospira spp 4  (3)  
 C. pneumoniae 2  (1) 
 S. aureus 2  (1) 
 M. catarrhalis 1  (1) 
 B. cepacia 1  (1) 
  Subtotal  25 (17) 
  
More than one pathogen*  
 Viral infection with superimposed bacterial infection  24 (16) 
 Tuberculosis with superimposed infection     3  (2) 
 Other mixed infections  15 (10) 
 Subtotal 42 (28) 
  
Unknown etiology (no pathogen detected) 48 (32) 
 
*for further details, see Table 4 
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Combinations of pathogens in 42 patients are presented in Table 4. Frequent 
combinations of pathogens were K. pneumoniae + S. pneumoniae (n=5), adenovirus + K. 
pneumoniae (n=4), and influenza or coronavirus + S. pneumoniae (n=3 each). 
 
 
 
Table 4. Combinations of respiratory pathogens observed among patients with community-acquired 
pneumonia 
 
Pathogen 
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Influenza A/B    3 2  1 1 2  9 
PIV 1  1 1 2 1  1   7 
Adenovirus    1 4    1  6 
Rhinovirus    2 1 1 1   1 6 
Coronavirus 1 1  3 1   2 2  10 
hMPV      1  1 2  4 
RSV    1 1      2 
K. pneumoniae   1 5  2  1 1  10 
C. pneumoniae   1        1 
M. pneumoniae    1       1 
L. pneumophila    1       1 
S. pneumoniae       1    1 
M. catarrhalis         1  1 
Total 2 1 3 18 11 5 3 6 9 1 59 
 
PIV= parainfluenza virus,  hMPV= human metapneumovirus, RSV= respiratory syncitial virus, GNB= Gram - 
Negative Bacilli. Note: 42 patients with multiple infection, of which 35 had 2 pathogens, 6 had 3 pathogens 
(Rhinovirus + S. pneumoniae + S. aureus, Adenovirus + K. pneumoniae + S. pneumoniae, Adenovirus +K. 
pneumoniae + other GNB, Coronavirus+ K. pneumoniae + M. catarrhalis, RSV type A + K. pneumoniae + S. 
pneumoniae, Parainfluenza + K. pneumoniae + S. pneumoniae) and 1 patient had 4 pathogens (Coronavirus + 
hMPV + K. oxytoca + M. catarrhalis) 
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The etiology of CAP could not be elucidated in 48 (32%) patients. Pathogen detection 
was, predictably, related to the availability of diagnostic specimens. Out of 48 cases with 
unknown etiology, only one patient had complete laboratory specimens from which all 
tests results were negative. The other 47 had incomplete laboratory specimens; 46 of 
them had no positive results, and one had so many positive serology results that no 
conclusion could be drawn. Patients with severe disease (PSI class IV–V) were less likely to 
receive an etiological diagnosis compared to those with non-severe disease (PSI class I-III, 
P=0.01). 
One isolate of K. pneumoniae was an ESBL-producer, while the others were susceptible 
to  antibiotics except to piperacillin (81% resistant) and nitrofurantoin (76% resistant). Of 
four regrowable S. pneumoniae, all were susceptible to penicillin, erythromycin, and 
vancomycin; one was intermediately resistant to co-trimoxazol, and three were resistant 
to tetracyclin. 
 
Clinical outcome 
There was no significant difference in underlying diseases, PSI class, length of stay, and 
mortality among patients with single viral, single bacterial, and mixed viral-bacterial 
infections (P>0.05). Patients with mixed-viral and mixed-bacterial infections were not 
analysed due to small numbers. The overall 30-day mortality rate was high (30%) and 
significantly associated with severity of disease (P<0.001). The mortality rate ranged from 
17%  in PSI class I patients to 80% in PSI class V patients. Interestingly, survival analysis 
showed a significantly lower survival rate in patients with unknown etiology (Figure 1). 
Early death (<48 hours of hospitalization) happened in 18 patients (41% mortality), and 
was associated with respiratory failure or irreversible septic shock; most of the early 
deceased patients (14 subjects) had delayed or no access to ICU care because of limited 
availability of the service. Late death (>48 hours of hospitalization) occured in 14 patients 
(32% of mortality), and was associated with worsening conditions from CAP (7 patients) or 
with their underlying diseases (7 patients). Despite clinical improvement, 12 patients (27% 
of mortality) died after discharge from hospital for in-home recovery within 30 days of 
admission. The circumstance  of these latter death remained  unknown.  
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Figure 1. Survival of patients with Community-acquired pneumonia according to diagnostic yield. 
 
 
DISCUSSION 
 
This is the first CAP etiology study conducted in Indonesia applying a full-range of 
microbiology tests. Influenza viruses, K. pneumoniae, and S. pneumoniae were the 
commonest agents with no correlation to the underlying diseases, severity, and outcome 
of CAP.  
Viral infections were surprisingly common, either as single or combined etiology. PCR 
was instrumental in detecting most respiratory viruses. A recent report from Thailand 
found viruses in 9% of hospitalised adult CAP patients in Northern Thailand [2] and in 25% 
of adult CAP patients admitted from a pneumonia surveillance in two other provinces [15]. 
Incidence of influenza A infection was 7.4% in hospitalised CAP [15] and 7% in severe CAP 
[5].  The use of PCR may, thus, enhance the appropriate use of antimicrobial agents [16]. 
No other CAP studies in Southeast Asia so far have attempted to diagnose viruses. 
 
More than one pathogens 
Single pathogen 
No pathogen detected 
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K. pneumoniae and other GNB were frequently observed in our study, similar to 
reports from other Southeast Asian countries [2,3,17], but different from those from 
Europe, North America, or Australia [1,18,19]. The high prevalence of K. pneumoniae and 
other GNB might, in part, be explained by the common carriage of these bacterial species 
in the nasopharynx of healthy individuals in the same area [20]. The tropical climate with 
higher temperature and humidity in Semarang may increase the incidence of GNB 
infection, as those conditions promote the growth and virulence of GNB [21,22]. 
S. pneumoniae infection was detected in only 13% of the patients, mostly by urinary 
antigen tests. Cultures frequently failed to grow this species, possibly due to the common 
use of antibiotics in the comunity, underlining the importance of alternative methods to 
detect pneumococci, as by PCR [3] or urinary antigen test [23].  However, a positive 
finding with the latter test should be interpreted carefully particularly in patients with 
COPD [23]. Previous studies in Southeast Asia reported various numbers for the relative 
contribution of  S. pneumoniae, from 2% [17]  through 52% [24] depending on the study 
population and the laboratory methods, while studies from Europe, North America, and 
Australia consistently reported it as the most common cause of  CAP [1,18,19].  
Aside from the climate, the differences in CAP etiology in our study compared to above 
studies might also relate to differences in patients age, underlying diseases, and 
radiological type of pneumonia. Our patients were relatively younger, had more often 
cerebrovascular underlying diseases, and had more often bronchopneumonia in stead of 
lobar or alveolar pneumonia. The wide spread use of influenza vaccination in other parts 
of the world may help explain the differences in the incidence of  influenza in CAP. Taken 
together, these differences imply that a guideline of CAP management construed and 
implemented in Europe, North America, and Australia might not be directly applicable in 
Indonesia.   
Most CAP studies distinguished the definite from probable etiology based on 
microbiology results. We did not use this distinction, instead, we interpreted 
microbiological, clinical and radiological findings in a multidisciplinary discussion to make a 
final diagnosis, since in our opinion, clinical data can not be omitted in doing so. 
Extending the range of  laboratory diagnostics applied to include viral as well as 
bacterial and fungal pathogen will, predictably increase the number of pathogens 
detected, and, thereby,  increase the chance of finding  polymicrobial infections [4,25]. We 
found mixed infection in a sizable proportion of the cohort of patients included in the 
study.  Some of this mixed infections are common, e.g. viral infection with superimposed 
bacterial infection [26] and tuberculosis with superimposed infection. Other mixed 
infections, e.g. by multiple bacteria or multiple viruses, are more difficult to understand 
and pose the problem of discriminating between infection and carriage. 
Most bacteria causing CAP in our study were susceptible to early generation 
antibiotics. These findings are consistent with other observation from Indonesia [27,28]. 
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Hence, the choice of antibiotics for the initial empirical treatment of CAP should not 
include the later generation of antibiotics, including a third generation cephalosporin 
which is recommended by the local guideline [29]. A more appropriate choice to consider 
would be amoxicillin-clavulanic acid or ampicillin-sulbactam. 
The crude mortality rate was high, and related to severity of the disease. However, 
even in low risk patients, the mortality in our study was still quite high, not only compared 
to that in North-America and Europe, but also to other studies from Southeast Asian 
countries [2,5]. The high mortality observed in our study suggests problems in the patient 
care process which needs further analysis. Determinants of poor outcome may  at least in 
part,  include delay in presenting to the hospital, inappropriate initial treatment, limited 
access to mechanical ventilators, inappropriate  antibiotic therapy, underlying diseases, 
and the severity of the disease on admission (to be published elsewhere). Interestingly, 
mortality was significantly higher among patients with unknown etiology. This finding may 
be explained by limitations in acquiring appropriate laboratory samples due to the severity 
of the disease at the time the patients were admitted. This is rather unfortunate, since 
these patients are those who need most to be managed based on an established etiology. 
This finding implies the need to perform all diagnostic procedures early, without delay, 
especially in patients with severe disease, so that the etiology of CAP in this group is 
established early, at a time its management can still be optimised. 
Since this study observed one city in Indonesia, involving only two hospitals, our data 
might not be representative for Java or Indonesia. The incomplete laboratory specimens in 
some patients might limit the opportunity to reveal complete etiology of CAP. 
 
 
CONCLUSIONS 
 
Multicenter CAP studies which include viral etiologies, should be carried out in Indonesia 
and other countries in this region to delineate the full spectrum of etiological agents in 
CAP patients and to generate local guidelines for the management of CAP.   
Bacteria causing CAP in this area of the world continue to present wild type antibiotic 
susceptibility profiles so that early generation antibiotics can be used as initial empiric 
treatment, thereby avoiding the selection pressure exerted by newer generations of 
antibiotics, especially third generation cephalosporins. The frequent incidence of GNB 
infection requires initial therapy to cover GNB in addition to pneumococcus. Optimal 
bacteriological diagnostics are required to be able to adapt initial therapy, including 
alternative tests for detecting S. pneumoniae. Performing all diagnostic procedures early, 
without delay, should be prioritized since establishing an etiological diagnosis is likely to 
improve clinical outcomes. 
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ABSTRACT 
 
Background 
Leptospirosis has a high incidence and mortality in many other tropical/sub-tropical 
countries. Pulmonary involvement in leptospirosis ranges from atypical symptoms to 
severe pulmonary hemorrhage syndrome and acute respiratory distress syndrome. 
Method 
We report 4 cases fulfilling the criteria for clinical diagnosis of community-acquired 
pneumonia (CAP), with additional clinical findings suggestive of leptospirosis. 
Confirmatory laboratory for Leptospira sp. infection was performed using serology tests of 
ELISA, microscopic agglutination test (MAT),  and real-time PCR (qPCR) 
Results 
Three patients had both a positive qPCR and a positive outcome on paired samples for the 
serological tests including microscopic agglutination test (MAT), IgM or total Ig (Ig T) 
ELISA; one patient had only a positive score in the serological tests, and one patient, from 
whom only acute samples (acute serum, urine, throat swab) were available, had a positive 
qPCR only. The results of qPCR on acute sera were in accordance to those from throat 
swabs.  
Conclusion 
Pathogenic Leptospira might be a causative agent of CAP in these patients. qPCR and 
serological testing are complementary when seeking a definite diagnosis of leptospirosis, 
depending on the disease stage at which the patient is admitted. qPCR from throat swab 
may present a novel non-invasive approach in the molecular diagnosis of leptospirosis. 
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INTRODUCTION 
 
Leptospirosis is a globally important zoonotic disease, that is highly prevalent in tropical or 
sub-tropical countries [1]. In Indonesia, leptospirosis is an important  public health 
problem with high incidence and mortality [2-4]. Multiorgan involvement is a common 
feature in leptospirosis, especially in icteric-severe cases [5,6]. The reported incidence of 
pulmonary involvement in leptospirosis varies from 20 to 70% [7,8]. Clinical 
manifestations of pulmonary involvement range from atypical symptoms like cough, 
pleuritic chest pain, dyspnea, hemoptysis to severe pulmonary hemorrhage syndrome and 
acute respiratory distress syndrome [7,9-11]. 
We report 4 cases of laboratory–confirmed leptospirosis in patients with pulmonary 
involvement mimicking community-acquired pneumonia (CAP) and who were diagnosed 
as such, at the time of enrollment in the framework of a clinical study of CAP .  
 
 
CASE DESCRIPTION AND LABORATORY METHODS 
 
During a clinical study of CAP performed in the Dr. Kariadi Hospital and Municipal Hospital, 
Semarang, Indonesia,  from 2007 to 2009, 148 patients fulfilled the criteria for clinical 
diagnosis of CAP as described elsewhere [12]. Five out of  those patients  had other clinical 
findings suggestive of leptospirosis. The sera of these five patients were tested positive 
with rapid tests by LeptoTek Dri Dot (Organon Teknika BV; Boxtel, The Netherlands) or 
Leptocheck-WB (Zephyr Biomedical, Vierna, Goa, India).     
 The patients’ paired sera (4-week interval) were further tested by the microscopic 
agglutination test (MAT) and an in-house ELISA as previously described [13,14] . DNA from 
sputum samples and throat swabs was  extracted using NucliSENS® easyMAG® 
(bioMérieux, Durham, UK). Extraction of DNA from urine and sera and the subsequent 
real-time polymerase chain reaction (qPCR) were performed  as previously described by 
Ahmed and co-workers [15]. In this clinical study, other microbiological tests (blood and 
sputum cultures, serology and PCR for respiratory pathogens  including influenza, 
rhinovirus, parainfluenza, adenovirus, human metapneumovirus, coronavirus 2293E, 
coronavirus OC43, coronavirus NL63, bocavirus, Mycoplasma pneumoniae, Legionella 
pneumophila, and Chlamydia pneumoniae  and urinary  antigen tests for Streptococcus 
pneumoniae and L. pneumophila) were performed as previously described [16-18] to 
elucidate the  etiology of CAP in Indonesia. The findings of the microbiology tests are 
summarized in Table 1. 
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Case 1 
A woman, 65-years old, with a history of fever for 4 days, headache, chills, dry cough and 
dyspnea, presented to the emergency room with temperature of 39.0º C, respiratory rate 
(RR) of 32 breaths per minute, blood pressure (BP) of 120/80 mmHg, and pulse rate (PR) 
of 110 per minute. She had conjunctival suffusion, crackles in both lungs on auscultation, 
and abdominal tenderness on palpation.  Her white blood cell count (WBC) was 12,600/µl, 
while thrombocyte count was 20,000/µl. Chest-X ray (CXR) showed infiltrates in both 
lungs. She was diagnosed as having CAP with a PSI (pneumonia severity index) score [12] 
of 135, and a CURB-65 (confusion, uremia, respiratory rate, blood pressure, and age 65 or 
older) score [13] of  4, compatible with severe/high risk pneumonia. She was treated with 
ceftriaxone 2 gram once daily, and recovered after 14 days. The cultures, serology and 
PCR for respiratory pathogens and the urinary antigen tests were all negative. Lepto Tek 
Dri Dot rapid test was positive. ELISA showed significant titer rise of IgM and total 
immunoglobulin (IgT) (Table. 1). MAT showed seroconversion for serovar Bataviae strain 
Swart.  The qPCR performed on acute sera, urine, and throat swab were positive, while on 
sputum and convalescent serum were negative (table 1). 
  
Case 2 
A male, 58-years old, with 4 days fever, dry cough and dyspnea, presented to the 
emergency ward with  temperature  of 39.5°C, RR of 28 breaths per minute, BP of 130/70 
mmHg, PR of 92 per minute and icteric sclerae. Crackles were heard over the right lower 
lung, compatible with the infiltrates on CXR. WBC was 6,800/µl, thrombocyte count was 
101,000/µl, and serum creatinine was 1.68 mg/dl.  Leptocheck-WB was positive.  The 
diagnosis was CAP with a PSI score of 78 and CURB-65 score of 1, compatible with low risk 
pneumonia. The patient was treated with ceftriaxone 2 gram once daily and recovered 
after 5 days. ELISA showed marked increases of IgM and IgT titers (Table 1) and MAT 
showed a seroconversion for serovar Bataviae strain Swart. The qPCR was positive on both 
the acute serum and throat swab, and negative on convalescence serum and urine 
samples. Other microbiology tests were negative except for rhinovirus PCR (Table 1). 
 
Case 3 
A 72 year-old male with a history of fever, dry cough and dyspnea for 7 days 
presented to the hospital with a temperature of 37.7 oC, an RR of 28 breaths per minute, a 
BP of 130/70 mmHg and PR of 120 per minute. His sclerae were icteric; petechiae and 
gum bleeding were found. Crackles were heard over the lower part of both lungs. WBC 
was 11,700/µl, thrombocyte count was 45,000/µl, serum alanine aminotransferase was 
104 U/l, total bilirubin 4.01 mg/dl, serum creatinine was 1.68 mg/dl, and potassium 3.1 
mmol/l. The CXR showed infiltrates in both lungs.  He was diagnosed with CAP with a PSI 
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score of 92 (high risk pneumonia) and a CURB-65 score of 2. He was treated with 
cefotaxime 1 gram i.v. three times daily for 2 days, followed by doxycycline 100 mg orally 
twice daily, and recovered after 7 days. The other microbiological tests  yielded no 
causative agent for the pneumonia. Lepto Tek Dri Dot was positive. ELISA showed low to 
moderate titers on the paired sera but MAT showed a seroconversion for serovar Bataviae 
strain Swart (Table 1). Leptospira qPCR was positive on both the acute serum and throat 
swab, but was negative on urine, convalescent serum and sputum samples.  
Serology tests also showed seroconversion of IgM antibody to C. pneumonia from <50 
to 179. However in the final comprehensive panel discussion to conclude the etiology of 
CAP in this patient, this finding was considered inconclusive since the clinical pictures did 
not support a C. pneumonia pneumonia and the PCR for C. pneumonia were negative. 
 
 
Case 4  
A male, 33 years old, with no significant past medical history, presented to  the emergency 
room with cough, fever (38.6oC), and dyspnea (RR 26/minute). His sclerae were icteric 
with conjunctival suffusion. Calf tenderness was found; crackles were heard in both lungs. 
He produced little non-purulent sputum.  He had acute kidney injury (ureum and 
creatinine levels were 288.0 mg/dl and 7.02 mg/dl, respectively). The levels of total and 
direct bilirubin were 4.85 mg/dl and 3.54 mg/dl, respectively. WBC was 12,300/µl, 
thrombocyte count was 21,000/µl. The CXR showed infiltrates in both lungs.  CAP was 
diagnosed with a PSI score of 83  and CURB-65 of 1 (low risk pneumonia). He was treated 
with ceftriaxone 2 gram once daily and recovered after 8 days. The other microbiological 
tests were negative. The Lepto Tek Dri Dot test was positive; MAT was negative on the 
single serum sample that was obtained (Table 1). We did not obtain a sputum sample 
from this patient. qPCR for Leptospira was positive on both the serum sample and throat 
swab.  
 
 
DISCUSSION  
 
All patients described in this paper were admitted to the hospital with radiologically 
confirmed CAP, and had other clinical manifestations consistent with leptospirosis which 
was subsequently confirmed by the laboratory [14]. The sera and throat swabs of these 
patients were positive by qPCR specific for pathogenic Leptospira. The results of PCR from 
throat swabs seemed to correlate with those from acute sera, but not with those from 
convalescent sera nor urine, implying the presence of pathogenic Leptospira in the 
respiratory tract in the acute phase of the disease.  
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Leptospires from pulmonary tissue may reach the throat via expectorated sputum, 
although this hypothesis is challenged by the fact that our sputum samples (available only 
from two patients) scored negative in the qPCR. This might be explained by the fact that 
performance of PCR on sputum samples is notoriously difficult and needs specific pre-
treatments of the samples, prior to DNA extraction and PCR. Moreover, the sputum 
quality from the patients was not good, containing only few (<10) leukocytes/LPF. Thus 
the negative results obtained by qPCR might be rather due to inhibition of the qPCR than 
to the absence of leptospires in the sputum, or due to a low concentration of leptospires. 
Further research will be needed to confirm or refute the mechanism of transport of 
leptospires from the lungs to the throat by sputum. Alternatively, the presence of 
leptospires in the oral mucosa associated by absence of the bacterium in the sputum 
might be explained by invasion of the mucous membranes by leptospires from the arteria.  
Our finding that qPCR results on throat swabs from CAP patients were in accordance 
with the qPCR results on serum samples, is also highly interesting from a practical point of 
view as this implies the potential of a non-invasive approach for early acute diagnosis of 
leptospirosis. Further research will be needed to enable a more solid estimation of the 
diagnostic accuracy of this approach as well as to find out whether this method can only 
be applied to CAP patients or has a broader applicability for leptospirosis patients in 
general.  
Three patients presented with serogroup Bataviae infections, presumably with serovar 
Bataviae , suggesting that this serovar is common in the Semarang area. 
The qPCR is an attractive diagnostic tool for the early diagnosis of leptospirosis when 
antibiotic treatment is most effective [8,15,16]. The test is highly sensitive when applied 
on blood samples taken at the early acute phase but loses diagnostic value in the 
immunological phase when leptospires are cleared from the blood. After seven days, 
Leptospira can be found in the urine [17], although shedding of leptospires in the first 
days after onset of the disease has been reported [18]. The qPCR on urine samples, as a 
non-invasive approach for early diagnosis, is, however, not obvious. The excretion of 
Leptospira in urine may be intermittent or late and the concentrations might have been 
beyond the detection limit [19].  In addition, urine contains inhibitors of the PCR that may 
not have been completely removed from the sample when applying standard commercial 
extraction kits [8].  
Since the decline of the diagnostic sensitivity of qPCR occurs in line with the increasing 
sensitivity of serological tests, qPCR and MAT are complementary when seeking a definite 
diagnosis of leptospirosis, depending on the disease stage at which the patient is 
admitted. 
Pulmonary radiographic alterations in leptospirosis have been frequently reported, 
with peripheral diffuse nodular densities, diffuse ground-glass density and confluent 
pulmonary lesions as common patterns, all usually bilateral [20-22]. These CXR patterns 
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can be ascribed to pulmonary haemorrhages, but they are not specific, because such 
findings are also compatible with pneumonia in general [23].  
The patients in our study may have suffered from leptospirosis with pulmonary 
involvement resembling pneumonia or haemorrhagic pneumonitis, and were, therefore, 
diagnosed as CAP at the time of their admission to hospital.  However, leptospirosis 
patients with pulmonary haemorrhages have a high mortality rate varying from 20 to 70% 
[4]. In our series, albeit small, all patients survived and did not have haemoptysis nor 
other bleeding manifestations, except for case number 3. It seemed that the pulmonary 
involvements in our series were not critical pulmonary haemorrhages but should rather be 
regarded as pneumonia caused by pathogenic Leptospira given that the CXR confirmed 
the presence of infitrates. Pneumonia due to leptospirosis was reported previously but 
the diagnosis of pneumonia was made by clinical manifestations and supported only by 
MAT [24].      
The microbiological diagnosis of CAP depends on the detection of pathogens from 
appropriate samples of blood, pleural fluids, sputum, bronchoalveolar lavages and 
nasopharyngeal swab [25]. Detection of respiratory viruses from throat swab by PCR has a 
diagnostic value in exploring the etiology of CAP [11]. We question whether the detection 
of pathogenic Leptospira by qPCR in throat swabs as in our cases may likewise have 
diagnostic value in that Leptospira are the causative pathogens of CAP among those 
patients, in particular case 1, 3, and 4  in whom Leptospira  was the only pathogen  
identified as the cause of  CAP.  The positive findings of rhinovirus in case 2 might indicate 
a co-infection; co-infections being common among CAP patients in our clinical study. 
High dose of  penicillin G is the antibiotic of choice for (severe ) leptospirosis [26,27]. 
However, in Indonesia, until currently penicillin is available only as penicillin G procain for 
the intramuscular injection while that for the intravenous injection (penicillin V) is not 
available. Clinicians are reluctant to administer penicillin G since intramuscular injection 
four times per day is inconvenient for both patients and health care workers. Parenteral 
ceftriaxone was then selected because it is also effective for leptospirosis and has a 
convenient dosing once  per day [27]. This drug is also one of the first choices for CAP 
according to the Indonesian guideline [28]. All patients in this series received empiric 
therapy with ceftriaxone, except one case with cefotaxime, and all responded well to 
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should minimize the use of ceftriaxone, for instance by early switching therapy to 
doxycycline or amoxicillin orally once the patients reach clinical stability [29] as applied in 
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can be ascribed to pulmonary haemorrhages, but they are not specific, because such 
findings are also compatible with pneumonia in general [23].  
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involvement resembling pneumonia or haemorrhagic pneumonitis, and were, therefore, 
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[4]. In our series, albeit small, all patients survived and did not have haemoptysis nor 
other bleeding manifestations, except for case number 3. It seemed that the pulmonary 
involvements in our series were not critical pulmonary haemorrhages but should rather be 
regarded as pneumonia caused by pathogenic Leptospira given that the CXR confirmed 
the presence of infitrates. Pneumonia due to leptospirosis was reported previously but 
the diagnosis of pneumonia was made by clinical manifestations and supported only by 
MAT [24].      
The microbiological diagnosis of CAP depends on the detection of pathogens from 
appropriate samples of blood, pleural fluids, sputum, bronchoalveolar lavages and 
nasopharyngeal swab [25]. Detection of respiratory viruses from throat swab by PCR has a 
diagnostic value in exploring the etiology of CAP [11]. We question whether the detection 
of pathogenic Leptospira by qPCR in throat swabs as in our cases may likewise have 
diagnostic value in that Leptospira are the causative pathogens of CAP among those 
patients, in particular case 1, 3, and 4  in whom Leptospira  was the only pathogen  
identified as the cause of  CAP.  The positive findings of rhinovirus in case 2 might indicate 
a co-infection; co-infections being common among CAP patients in our clinical study. 
High dose of  penicillin G is the antibiotic of choice for (severe ) leptospirosis [26,27]. 
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In conclusion, patients with leptospirosis may present with symptoms resembling CAP. In 
tropical, humid areas, leptospirosis should be included in the differential diagnosis of 
patients with CAP. The value of a PCR specific for pathogenic Leptospira spp. on throat 
swabs should be further explored. 
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ABSTRACT 
 
Introduction 
Nasopharyngeal carriage of Streptococcus pneumoniae precedes pneumonia and other 
pneumococcal diseases in the community. Little is known about S. pneumoniae carriage 
in Indonesia, complicating strategies to control pneumococcal diseases. We investigated 
nasopharyngeal carriage of S. pneumoniae in Semarang, Indonesia. 
Methods 
A population-based survey was performed in Semarang, Indonesia. Nasopharyngeal 
swabs and questionnaires were taken from 496 healthy young children (6-60 month-old) 
and 45-70 year-old adults. 
Results 
Forty-three percent of children aged 6-60 months and 11% of adults aged 45-75 years 
carried Streptococcus pneumoniae. Determinants of carriage were being a child (OR 7.7; 
95% CI = 4.5-13.0), passive smoking (OR 2.1; 95% CI = 1.3-3.4), and contact with 
toddler(s) (OR 3.0; 95% CI = 1.9-4.7). The most frequent serotypes found were 6A/B and 
15B/C. The current commercially available vaccines cover <50% serotypes found in 
children. Twenty-four percent of S. pneumoniae strains were penicillin non-susceptible, 
and 45% were resistant to co-trimoxazol.  
Conclusions 
The limited coverage of commercially available vaccines against the serotypes found in 
this population, and the high proportion of non-susceptibility to penicillin and co-
trimoxazol suggest the need for region-specific strategies to control S. pneumoniae. 
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INTRODUCTION 
 
Streptococcus pneumoniae is a worldwide occurring pathogen [1]. Data on this species 
are abundantly available in developed countries, but still scarce in low-to-middle-income 
countries, leading to difficulties in designing national strategies to control pneumococcal 
diseases.  
Since pneumococcal pneumonia is preceeded by nasopharyngeal colonization with S. 
pneumoniae [2], it is relevant to study the nasopharyngeal carriage pattern in humans, 
particularly in those at higher risk of pneumonia. This has already been extensively 
studied in many parts of the world, but only few data are available from Indonesia [3], 
the fourth most populated country in the world. We investigated the nasopharyngeal 
carriage of S. pneumoniae in Indonesia, to learn the prevalence, risk factors, serotypes, 
and antimicrobial susceptibility. 
 
 
METHODS 
 
Ethics statement 
The study was approved by The Ethical Committee of the Faculty of Medicine, 
Diponegoro University, Semarang. Written informed consent was given by the subjects 
or their caregivers. 
 
Subjects  
A population-based survey was performed in Semarang, a city with 1.5 million residents 
in Central Java, among healthy children aged 6-60 months and healthy adults aged 45-70 
years as described before [4]. Exclusion criteria were the presence of respiratory 
symptoms and antibiotic consumption within the last three days. Cluster random 
sampling was done from February to April 2010 to recruit subjects from all 16 districts of 
Semarang.  
 
Specimen collection and Laboratory testing 
Nasopharyngeal swabs were obtained using rayon-tipped swabs and transported in 
Amies-charcoal media (COPAN, Italy). Swabs were inoculated on 5% sheep blood agar 
with gentamicin (5 mg/liter) and incubated at 35oC in 5% CO2 for 48 hours. Identification 
of S. pneumoniae was performed using the optochin test (Oxoid, Basingstoke, UK) and, in 
case of doubt, a DNA hybridization test (Accuprobe, Gen-Probe Inc., San Diego, CA, USA). 
Disk diffusion antimicrobial susceptibility tests were performed and interpreted 
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according to EUCAST 2012. Serotyping of S. pneumoniae was done with a multiplex-PCR 
which covers 36 serotypes [5,6]. Control strains were included in all analyses.  
Using a questionnaire that was developed to identify determinants of carriage, data 
on demography, house sanitation (crowding, smoke exposure from cigarette and 
mosquito coils), and water and food hygiene were recorded. Crowding was defined 
present if the ratio of total bedroom space to the number of family members was less 
than 4 m2 [7]. Water hygiene was defined as poor when water other than tap or bottled 
water was used by the family. Food hygiene was considered poor if the family consumed 
street food.  
 
 
Statistical Analysis 
Univariate analysis was done with Chi-square or Fisher’s exact tests when appropriate, 
followed by backward stepwise logistic regression for variables with P value <0.2 using 
SPSS 17 (SPSS Inc, Chicago, USA). P value of <0.05 was considered significant.  
 
 
 
RESULTS 
 
Subjects 
Two hundred and fifty-three adults aged 45–70 years and 243 children aged <6 years 
participated in the study. The characteristics of the participants have been shown 
previously [4]. Crowding was common, as was exposure to smoke. 
 
Carriage prevalence and determinants 
Overall carriage of S. pneumoniae was 27% (95% CI = 20-32), 43% in children, and 11% in 
adults. The proportion carrying S. pneumoniae varied significantly across the districts of 
Semarang, and tended to be higher in the suburban and eastern parts of the city (Figure 
1).  
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Figure 1. Distribution of nasopharyngeal carriage of S. pneumoniae in the districts of Semarang 
 
 
Serotype distribution significantly differed between  the isolates from adults and children 
(p<0.05, table 1). Serotype 6A/6B was the most frequently isolated from both adults and 
children.   
 
 
   Table 1. Serotype of S. pneumoniae isolated from healthy people in Semarang 
 
Children 
n (%) 
Adults 
n (%) 
Total 
n (%) 
p 
6A/6B 21 (19)  12 (39) 33 (23) 0.029 
15B/C 11 (10) 4 (13)  15 (11)  
11A 11 (10) 1 (3)  12 (8)  
23F 10 (9)  1 (3)  11 (8)  
19F 9 (8)  0 (0) 9 (6)  
23A 5 (5) 0 (0) 5 (4)   
15A 2 (2) 3 (10) 5 (4)   
Others 22 (20) 2 (6)  24 (17)   
Untypeable 20 (18)  8 (26)  28 (20)  
 Total 111 (100) 31 (100) 142 (100)  
 
 
Multivariate analysis showed that being a child (OR 7.7, 95% CI, 4.5-13.0), passive 
smoking (OR 2.1, 95% CI, 1.4-3.4), and contact with toddler(s) at home (OR 3.0, 95% CI, 
1.9-4.7) were independent determinants of carriage.  
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Antimicrobial susceptibility and serotypes 
One hundred and forty-two strains were isolated from 133 subjects. In total, 34 (24%) 
strains were penicillin non-susceptible (MIC ranged 0.047-1.5), including 25 (23%) from 
children and 9 (29%) from adults (P=0.25). Forty-five percent of the strains were 
resistant to co-trimoxazol, 1% to erythromycin, and 5% to tetracycline. There was no 
significant difference in the susceptibility pattern between isolates from children and 
those from adults (P>0.1).  No strain was resistant to penicillin or to vancomycin. 
Capsular type 6A/B was the most prevalent serotype in all age groups (19% in 
children and 39% in adults). The most common capsular serotypes in children, 
comprising 61% of strains, were 6A/B, 15B/C, 11A, 23F, 19F, 23A. Those in adults, were 
6A/B, 15B/C, and 15A.  These two serotype patterns differed significantly  (P=0.029). 
Other serotypes were less frequently found (Table 1). Nineteen percent were untypeable 
with the multiplex-PCR employed. 
 
 
DISCUSSION 
 
The carriage prevalence of S. pneumoniae among children in our study was comparable 
to those previously found among healthy children in Lombok, Indonesia [3], and in the 
Netherlands [8], but lower than those in Gambia [9], Poland [10], Australia [11], Thailand 
[12], and higher than those reported from Iran [13] and Korea [14]. The carriage 
prevalence among adults in our study was 11%; higher than that in Alaska [15], but lower 
than that among Australian Aboriginals of the same age [11]. The prevalence differences 
among populations may be related to sampling or laboratory methods 
(i.e.nasopharyngeal swab versus throat swab, the use of selective media), to certain 
characteristics of the population studied (i.e. the age of the subjects, household 
characteristics – especially the presence of toddlers, presence of upper respiratory tract 
infection, vaccination status), or to seasonal variation. Our samples were taken in the 
rainy season, during which the incidence of respiratory tract infection is likely to be 
somewhat increased.  
The prevalence of S. pneumoniae with reduced susceptibility to penicillin and co-
trimoxazole was high. The national and local guidelines for empirical antibiotics for 
community-acquired pneumonia in children recommend these two antibiotics as the 
first choices [16], and those for meningitis recommend ampicillin for the second line 
[17]. 
The commercially available 13-valent pneumococcal conjugate vaccines (PCV13) [18], 
which was introduced in 2011, provides in average 45% strain coverage for the infant 
population in this study, ranged from 13-100% in each district.  PCV10 provides even 
lower coverage. However, the coverage of the  PCV13 over the serotype repertoir  in 
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other island in Indonesia in the past [3] was 60% and in other Southeast Asian countries 
[19] was higher (63%-97%). Our results may not be taken to reflect the serotype 
distribution throughout Indonesia, since the study was performed in a specific 
geographic location.  The PCVs have not been included in the national vaccination 
program, rather, it is introduced in private clinics as they are still probably considered 
very expensive for Indonesian setting, and no enough information regarding with 
pneumococcal disease and carriage in Indonesia. Studies failed to reveal the burden of 
pneumococcal diseases in Indonesia probably due to technical problems [20,21]. This 
underscores the importance of surveillance of pneumococcal disease in Indonesia using 
implementable methods. 
This study provides further evidence that passive smoking is an independent 
determinant of S. pneumoniae carriage among children [10,13]. The mechanism by 
which passive smoking influences the microbial ecology of the upper respiratory tract 
remains to be elucidated, however. 
 
 
CONCLUSION 
 
In conclusion, nasopharyngeal carriage of  S. pneumoniae was common among healthy 
children and adults in this part of the world, determined, at least in part, by the presence 
of toddlers in the household and smoking habit of the adults. The low coverage of 
commercially available vaccine against the serotypes found among children in the 
population, and the high proportion of non-susceptibility to penicillin and co-trimoxazol 
suggest the need for region-specific strategies to control S. pneumoniae. There is a need 
for a large epidemiological study on pneumococcal disease throughout Indonesia. 
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ABSTRACT 
 
Gram-negative bacilli (GNB) cause many pneumonia cases in Indonesia. We investigated 
nasopharyngeal carriage of GNB in Semarang, Indonesia. K. pneumoniae carriage in adults 
(15%) was higher than in children (7%,P=0.004), while that of other-GNB was comparable. 
Poor food and water hygiene were determinants of carriage.  
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INTRODUCTION 
 
Worldwide, Streptococcus pneumoniae is considered the most common cause of 
community-acquired pneumonia (CAP). However, in tropical low-to-middle-income 
countries, Klebsiella pneumoniae and other Gram-negative bacilli (GNB) are reported as 
frequent causes of CAP, more often that in high-income countries [1]. In a recent study on 
CAP etiolology in Indonesia, K. pneumoniae found as the most frequent agent (own 
observation, to be published elsewhere).  
Since nasopharyngeal colonization may preceed pneumonia, as demonstrated for S. 
pneumoniae [2], we investigated the prevalence of nasopharyngeal carriage of K. 
pneumonia and other-GNB among young children and adults in Indonesia, and that of S. 
pneumoniae as benchmark.  
 
 
METHODS 
 
Subjects were healthy children aged 6-60 months and healthy adults aged 45-70 years, 
free from respiratory symptoms, had no antibiotic consumption within the last three days, 
and living in Semarang, a city with 1.5 million residents in Central Java, Indonesia. Cluster 
random sampling was done from February to April 2010 to recruit subjects from all 16 
districts of Semarang.  
Nasopharyngeal swabs were obtained using rayon-tipped swabs and transported in 
Amies media (COPAN, Italy). Swabs were inoculated on 5% sheep blood-gentamycin 
5µmg/mL agar and on MacConkey agar. Plates were incubated at 35oC in 5%CO2 for 48 
hours. All GNB and putative  S.pneumoniae isolates were subcultured and stored in -80oC, 
and sent to Erasmus MC Rotterdam for identification using Vitek®2 (bioMérieux, Marcy 
l’Etoile, France) and optochin test (Oxoid, Basingstoke, UK). Antimicobial for the GNB  
susceptibility tests were performed using Vitek®2, interpreted according to CLSI 2010. 
Control strains were included in all analyses.  
A questionnaire was developed to identify determinants of carriage. Data on 
demography, sources of water used for family needs (drinking, preparing food, bathing), 
food hygiene and house sanitation (crowding, flies, smoke exposure from cigarette and 
mosquito coils), were collected. Water hygiene was considered poor when river water, 
well water, water sold by mobile vendors, or water from mobile tanks was used. Food 
hygiene was considered poor if bought from street vendors. Crowding was considered if 
the ratio of total bedroom space to the number of family members was <4 m2 [3]. 
Univariate analysis was done with Chi-square or Fisher’s exact tests when appropriate, 
followed by backward stepwise logistic regression for variables with P value <0.2 using 
SPSS 17 (SPSS Inc, Chicago, USA). Confidence interval (CI) was calculated on 95% level and 
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P values <0.05 were considered significant. The study was approved by The Ethical 
Committee of the Faculty of Medicine-Diponegoro University, Semarang. Written 
informed consent was given by the subjects or their caregivers.  
 
 
RESULTS 
 
Two hundred and fifty-three adults aged 45–70 years and 243 children aged < 6 years 
participated in the study; approximately one fourth resided in suburban area, and the 
majority was living under hygienically restricted circumstances regarding their food and 
water supplies. Crowding was common, as was exposure to smoke (Table 1). 
 
Table 1. Characteristics of the study participants 
  Children 
N=243 
n (%) 
Adults 
N=253 
n (%) 
Total 
N=496 
n (%) 
p 
Gender 
 
Male 118 (49) 94 (37) 212 (43) 0.01 
Female 125 (51) 159 (63) 284 (57)  
Age Median 2.1 yrs 55 yrs   
Range 0.5-5 yrs 45-75 yrs   
Residence Urban 180 (74) 186 (74) 366 (74) 0.9 
Suburban 63 (26) 67(26) 130 (26)  
Food hygiene Good 81 (33) 107 (42) 188 (38) 0.04 
Poor 162 (67) 146 (58) 308 (62)  
Water hygiene Good 114 (47) 119 (47) 233 (47) 0.9 
Poor 129 (53) 134 (53) 263 (53)  
Crowding *) No 129 (56) 157 (66) 286  (61) 0.03 
Yes 100 (44) 80 (34) 180 (39)  
Mosquito coils use No 184 (76) 170 (67) 354 (73) 0.04 
Yes 59 (24) 83 (33) 142 (29)  
Active smoking No  243 (100) 200 (79) 443 (89) 0.01 
Yes  0 (0) 53 (21) 53 (11)  
Passive smoking No 97 (40) 106 (42) 203 (41) 0.7 
Yes 146 (60) 147 (58) 293 (59)  
Contact with toddler(s) No 111 (46) 116 (46) 227 (46) 0.9 
Yes 132 (54) 137 (54) 269 (54)  
*) Only 366 subjects responded to this question 
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Overall, the carriage rate of K. pneumonia and other-GNB was 11% (95% CI, 7-14) and 
19,5 % (95% CI, 12-23) respectively. K. pneumoniae carriage in adults (15%) was higher 
than in children (7%, P=0.004), while that of other-GNB was comparable (20% vs 19%, P 
=0.7) (Table 2). As benchmark, overall carriage of S. pneumoniae was 27 % (95% CI, 20-32), 
43% in children, and 11% in adults. The carriage of these bacteria together in combination 
was common. The presence or the absence of carriage of one species was not correlated 
to that of other species (P >0.1). The proportion of carriage of these bacteria was not 
similar across the districts of Semarang, rather, carriage rates varied significantly and 
tended to be higher in the suburban and eastern parts of the city.  
Fifty-four K. pneumoniae strains were isolated from 54 subjects. Only one strain was 
resistant to cefotaxime and ceftriaxone, but the presence of an extended-spectrum beta-
lactamase (ESBL) could not be confirmed using ESBL confirmatory E-test. The remaining 
strains were all susceptible to the common antibiotics, including cefuroxime, but not to 
nitrofurantoin (43% being resistant or intermediate). 
 
 
Table 2. Distribution of nasopharyngeal colonization among young children and adults in Semarang, 
Java, Indonesia 
 
Carriage type 
Children 
N = 243 
n (%) 
Adults 
N = 253 
n (%) 
Total 
N = 496 
n (%) 
P 
Non-carrier  107 (44) 157 (62) 264 (53) 0.000 
Total of K. pneumoniae carrier 16 (7) 38 (15) 54 (11) 0.004 
Total of other-GNB*) carrier 49 (20) 47 (19) 96 (19) 0.7 
Total of S. pneumoniae carrier 105 (43) 28 (11) 133 (27) 0.000 
K. pneumoniae only 5 (2) 25 (10) 30  (6)  
Other-GNB only 22 (9) 39 (15) 61 (12)  
S. pneumoniae only 78 (32) 17 (7) 95 (19)  
K. pneumoniae and S. pneumoniae  4 (2) 7 (3) 11 (2) 0.000 
Other-GNB and S. pneumoniae  20 (8) 2 (1) 22 (4)  
K. pneumoniae and Other-GNB 4 (2) 4 (2) 8 (2)  
K. pneumonia, Other-GNB, and S. pneumoniae  3 (1) 2 (1) 5 (1)  
*) GNB = Gram-negative bacilli 
 
One hundred and seven GNB strains other than K. pneumoniae were found in 96 (19 
%) subjects, of whom 49 were children and 47 were adults. The three most frequently 
isolated other-GNB were Pseudomonas spp, Enterobacter spp and Acinetobacter spp 
(Table 3). Antimicrobial susceptibility test for  Enterobateriaceae other than K. 
pneumoniae  showed sensitivity of 100% to carbapenem, and of  >95% to piperacillin-
tazobactam, 3rd generation cefalosporins, gentamicin, ciprofloxacin. All Pseudomonas spp 
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isolates were susceptible to tobramycin,  meropenem, ciprofloxacin,  67% were 
susceptible to ceftazidime, and 87% were susceptible to colistin. 
Multivariate analysis showed that being an adult (OR 2.2, 95% CI, 1.1-4.2), poor water 
hygiene (OR 2.1, 95% CI, 1.1-3.9), poor food hygiene (OR 2.2, 95% CI, 1.1-4.3), and 
frequent use of mosquito coils  (OR 1.8, 95% CI, 1.1-4.3) were independent determinants 
for K. pneumoniae carriage. Poor water hygiene (OR 1.8, 95% CI, 1.1-2.9), poor food 
hygiene (OR 1.8, 95% CI 1.1-2.7) and being a female (OR 1.9, 95% CI, 1.2-3.1) were 
independent risk factors for carriage of other-GNB.  
 
 
 Table 3. Nasopharyngeal carriage of Gram-negative bacilli (GNB) 
Species Children 
N = 243 
n (%) 
Adults 
N = 253 
n (%) 
Total 
N = 496 
n (%) 
K. pneumoniae                             16 (7) 38 (15) 54 (11) 
Other-GNB  56 ** 51 ** 107** 
       Pseudomonas spp 16 (7) 9 (4) 25 (5) 
       Enterobacter spp 11 (5) 10 (4) 21 (4) 
       A.baumannii complex 11 (5) 3 (1) 14 (3) 
       Citrobacter spp 0 (0) 11 (4) 11 
       Aeromonas spp 6 (2) 3 (1) 9 
       Pantoea spp 6 (2) 3 (1) 9 
       Serratia spp 0 (0) 4 (2) 4 (1) 
       E.coli 0 (0) 3 (1) 3 (1) 
       S.maltophilia 1 (1) 1 (1) 2 (1) 
       Other non-lactose  
             fermenting bacilli * 
5 (2) 4 (2) 9 
* Other non-fermenting bacilli were C. testosteroni, L. adecarboxylata, R. radiobacter, P. vulgaris, B. militensis,   
S. algae, S. spiritivorum  
** six children carried 2 other-GNB, 4 adults carried 2 other-GNB 
 
 
 
DISCUSSION 
 
This is the first population-based study of nasopharyngeal carriage of GNB in Indonesia, a 
large low-to-middle-income Southeast-Asia country. The carriage rate of GNB was 
surprisingly high, exceeding that of S. pneumoniae in adults. Overall 30% of the 496 
participants carried GNB, with K. pneumoniae as the commonest GNB species (11%) which 
is significantly higher among adults as compared to children. Few publications are 
available regarding nasopharyngeal carriage by K. pneumoniae or GNB, since these 
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bacteria usually are not considered as commensals in the nasopharyngeal space of healthy 
individuals. K. pneumoniae and other-GNB carriage is usually related to specific 
conditions, such as preceding antibiotic therapy, underlying diseases or long hospital stay 
[4]. A study performed in Brazil, a high middle-income country (World Bank 2011) found 
that the carriage rate of GNB among 1192 children attending day care was 9%, but K. 
pneumoniae was found in only 1.4% of the subjects [5]. Our study showed that carriage of 
K. pneumoniae and other-GNB in healthy individuals in Semarang is much more common. 
K. pneumoniae carriage was related to poor hygiene, particularly water and food hygiene, 
and to mosquito coil smoke exposure. The determinants of carriage by other-GNB were 
also related to poor water and food hygiene.  
K. pneumoniae and many other-GNB present in the enteric micro-flora may serve as a 
source of water contamination particularly in countries with poor sanitation [6]. People 
who use contaminated water daily could, thus, become colonized. Food preparation using 
contaminated water or by contaminated persons may increases transmission to the oro-
nasopharynx. A study in Malaysia, a neighbour country of Indonesia, found that 32% of 
street food in Malaysia were contaminated by K. pneumoniae [7].  
Mosquito coils were also found as a K. pneumoniae carriage determinant. It had been 
demonstrated that one mosquito coil would release the same amount of particulate 
matter mass as burning 75-137 cigarettes [8]. 
The frequent carriage of K. pneumoniae and other-GNB may explain the frequent 
finding of these potential pathogens as etiology of pneumonia in previously healthy 
individuals in this part of the world [1]. However, the virulence profile of these isolates 
requires further study. Importantly in this respect, almost all strains of K. pneumoniae 
were found to have the wild type susceptibility to antimicrobial agents used for routine 
treatment of pneumonia, similar to those found in CAP patients in Semarang (own 
observation, will be published elsewhere). This finding also confirms findings from 
previous surveillance studies in the same community, where only few acquired resistance 
was found among enteric bacilli isolated from healthy people living in the community 
[9,10]. 
In conclusion, nasopharyngeal carriage of K. pneumoniae and other-GNB is common 
among healthy people in Indonesia, and is associated in part with exposure to external 
sources of these organisms in water and food. However, the pool of GNB found in the 
nasopharyngeal spaces of healthy individuals represents wild type strains in that they 
remain susceptible to antibiotics.  
 
 
ACKNOWLEDGMENT 
We thank study participants from Faculty of Medicine Diponegoro University, Susilo 
Prihranto from Internal Medicine Residency Program, Faculty of Medicine Diponegoro 
99Carriage of K. pneumoniae and Gram-negative bacilli
 
Carriage of K. pneumoniae and Gram-negative bacilli | 101 
 
 
bacteria usually are not considered as commensals in the nasopharyngeal space of healthy 
individuals. K. pneumoniae and other-GNB carriage is usually related to specific 
conditions, such as preceding antibiotic therapy, underlying diseases or long hospital stay 
[4]. A study performed in Brazil, a high middle-income country (World Bank 2011) found 
that the carriage rate of GNB among 1192 children attending day care was 9%, but K. 
pneumoniae was found in only 1.4% of the subjects [5]. Our study showed that carriage of 
K. pneumoniae and other-GNB in healthy individuals in Semarang is much more common. 
K. pneumoniae carriage was related to poor hygiene, particularly water and food hygiene, 
and to mosquito coil smoke exposure. The determinants of carriage by other-GNB were 
also related to poor water and food hygiene.  
K. pneumoniae and many other-GNB present in the enteric micro-flora may serve as a 
source of water contamination particularly in countries with poor sanitation [6]. People 
who use contaminated water daily could, thus, become colonized. Food preparation using 
contaminated water or by contaminated persons may increases transmission to the oro-
nasopharynx. A study in Malaysia, a neighbour country of Indonesia, found that 32% of 
street food in Malaysia were contaminated by K. pneumoniae [7].  
Mosquito coils were also found as a K. pneumoniae carriage determinant. It had been 
demonstrated that one mosquito coil would release the same amount of particulate 
matter mass as burning 75-137 cigarettes [8]. 
The frequent carriage of K. pneumoniae and other-GNB may explain the frequent 
finding of these potential pathogens as etiology of pneumonia in previously healthy 
individuals in this part of the world [1]. However, the virulence profile of these isolates 
requires further study. Importantly in this respect, almost all strains of K. pneumoniae 
were found to have the wild type susceptibility to antimicrobial agents used for routine 
treatment of pneumonia, similar to those found in CAP patients in Semarang (own 
observation, will be published elsewhere). This finding also confirms findings from 
previous surveillance studies in the same community, where only few acquired resistance 
was found among enteric bacilli isolated from healthy people living in the community 
[9,10]. 
In conclusion, nasopharyngeal carriage of K. pneumoniae and other-GNB is common 
among healthy people in Indonesia, and is associated in part with exposure to external 
sources of these organisms in water and food. However, the pool of GNB found in the 
nasopharyngeal spaces of healthy individuals represents wild type strains in that they 
remain susceptible to antibiotics.  
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ABSTRACT 
 
K. pneumoniae can colonize and cause infection in the respiratory tracts. We studied the 
diversity among the strains colonizing healthy subjects and those causing infection in 
pneumoniae patients. Strains from healthy and pneumonic adults were highly similar and 
possessed more virulance factors than those from healthy children. 
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BACKGROUND  
Klebsiella pneumoniae is an important pathogen causing  a wide range of infections. In 
Europe and North America the incidence of these infections is particularly high among 
alcoholics and hospitalised persons [1]. In  Southeast Asia, this pathogen is frequently 
reported as a cause of community-acquired pneumonia (CAP) [2]  and commonly found in 
the innate environment [3].  
K. pneumoniae is also a commensal of the nasopharynx and intestines. The carriage 
prevalence in the community in Europe and North America was reported to be 1-6% in 
nasopharynx and 5-38% in the intestinal tract. These rates increased markedly in 
hospitalised patients up to 19% in pharynx and 70% in intestinal tract [1]. In a recent 
study, we have showed a higher rate of nasopharyngeal carriage of K. pneumoniae among 
healthy adults and toddlers in Semarang, Indonesia, 15% and 7%, respectively [4]. In 
another study performed in the same area, K. pneumoniae was identified as the causative 
pathogen in 16% of adult CAP patients (own study, to be published elsewhere). This study 
aimed to describe the diversity of phenotypes and virulence factors of K. pneumoniae 
isolated from healthy individuals and from CAP patients the two aforementioned studies. 
 
 
MATERIAL AND METHODS 
K. pneumoniae subsp. pneumoniae strains from healthy individuals were isolated using 
nasopharyngeal swabs from 496 children and adults randomly selected from all 16 
districts in Semarang city in 2010 [4]. The included subjects aged 6-60 months or 45-70 
years, were free from respiratory symptoms and from antibiotic medication within the last 
three days. Strains from pneumonia patients were isolated from sputum or blood cultures 
of 148 adult CAP patients aged 45-70 years, hospitalised in Dr. Kariadi and Semarang 
Municipal hospitals in Semarang, Indonesia, during  2007-2009. The identification was 
performed using the Vitek2 system ( bioMérieux, Marcy l’Etoile, France). Antimicrobial 
susceptibility testing was performed using N140 Vitek2 cards. A confirmatory test for 
production of an extended-spectrum beta-lactamase (ESBL) was performed using E-test 
(bioMérieux). Hypermucoviscosity was assessed using a modified string test [5]. A 
multiplex PCR for K1, K2, K5, K20, K54, K57, rmpA, and wcaG was performed to detect the 
presence of genes related to capsular serotype and virulence factors [6]. 
Statistical analysis was performed using Chi-square or Fisher’s exact tests when 
appropriate using SPSS 17 (SPSS Inc., Chicago, USA). P value of <0.05 was considered 
significant.  
 
 
 
105Diversity among K. pneumoniae isolated from healthy subjects and pneumonia patients106 | Diversity among K. pneumoniae isolated from healthy subjects and pneumonia patients 
ABSTRACT 
 
K. pneumoniae can colonize and cause infection in the respiratory tracts. We studied the 
diversity among the strains colonizing healthy subjects and those causing infection in 
pneumoniae patients. Strains from healthy and pneumonic adults were highly similar and 
possessed more virulance factors than those from healthy children. 
 
 
Diversity among K. pneumoniae isolated from healthy subjects and pneumonia patients | 107 
 
BACKGROUND  
Klebsiella pneumoniae is an important pathogen causing  a wide range of infections. In 
Europe and North America the incidence of these infections is particularly high among 
alcoholics and hospitalised persons [1]. In  Southeast Asia, this pathogen is frequently 
reported as a cause of community-acquired pneumonia (CAP) [2]  and commonly found in 
the innate environment [3].  
K. pneumoniae is also a commensal of the nasopharynx and intestines. The carriage 
prevalence in the community in Europe and North America was reported to be 1-6% in 
nasopharynx and 5-38% in the intestinal tract. These rates increased markedly in 
hospitalised patients up to 19% in pharynx and 70% in intestinal tract [1]. In a recent 
study, we have showed a higher rate of nasopharyngeal carriage of K. pneumoniae among 
healthy adults and toddlers in Semarang, Indonesia, 15% and 7%, respectively [4]. In 
another study performed in the same area, K. pneumoniae was identified as the causative 
pathogen in 16% of adult CAP patients (own study, to be published elsewhere). This study 
aimed to describe the diversity of phenotypes and virulence factors of K. pneumoniae 
isolated from healthy individuals and from CAP patients the two aforementioned studies. 
 
 
MATERIAL AND METHODS 
K. pneumoniae subsp. pneumoniae strains from healthy individuals were isolated using 
nasopharyngeal swabs from 496 children and adults randomly selected from all 16 
districts in Semarang city in 2010 [4]. The included subjects aged 6-60 months or 45-70 
years, were free from respiratory symptoms and from antibiotic medication within the last 
three days. Strains from pneumonia patients were isolated from sputum or blood cultures 
of 148 adult CAP patients aged 45-70 years, hospitalised in Dr. Kariadi and Semarang 
Municipal hospitals in Semarang, Indonesia, during  2007-2009. The identification was 
performed using the Vitek2 system ( bioMérieux, Marcy l’Etoile, France). Antimicrobial 
susceptibility testing was performed using N140 Vitek2 cards. A confirmatory test for 
production of an extended-spectrum beta-lactamase (ESBL) was performed using E-test 
(bioMérieux). Hypermucoviscosity was assessed using a modified string test [5]. A 
multiplex PCR for K1, K2, K5, K20, K54, K57, rmpA, and wcaG was performed to detect the 
presence of genes related to capsular serotype and virulence factors [6]. 
Statistical analysis was performed using Chi-square or Fisher’s exact tests when 
appropriate using SPSS 17 (SPSS Inc., Chicago, USA). P value of <0.05 was considered 
significant.  
 
 
 
106 Chapter 6108 | Diversity among K. pneumoniae isolated from healthy subjects and pneumonia patients 
RESULTS 
 
In total, 75 K. pneumoniae subsp. pneumoniae strains were isolated; 54 from healthy 
subjects (16 from children, 38 from adults) and 21 from pneumonic adults.   
Phenotypically, 55%  strains from healthy adults and  48% strains from pneumonic adults 
were hypermucoviscous, while only 19% strains from children were hypermucoviscous 
(p=0.018, Table 1).  
 
Table 1.  Hypermucoviscosity of K. pneumoniae isolated from healthy children, healthy adults, and 
pneumonic adults 
Origin of Isolates HMV (+)* 
    n (%) 
HMV (-) 
 n (%)  
Total 
n (%) 
P 
Healthy children 3 (19) 13 (81) 16 (100)  
    0.018 
Healthy adults 21 (55) 17 (45) 38 (100)  
    0.598 
Pneumonic adults 10 (48) 11 (52) 21(100)  
* HMV, hypermucoviscosity 
 
Most strains were susceptible to the tested antibiotics (amoxicillin-clavulanic acid, 
piperacillin-tazobactam, cephalosporins, macrolides, carbapenems, ciprofloxacin, 
cotrimoxazole) except ampicillin (100% resistant). One ESBL strain was found from the 
pneumonic adult. There was no  difference  in the pattern of antimicrobial susceptibility 
among isolates from all three subgroups. 
 
Table 2. Capsular types of K. pneumoniae isolated from healthy children, healthy adults, 
and pneumonic adults 
 K1 
n (%) 
K2 
n (%) 
K5 
n (%) 
K20 
n (%) 
K54 
n (%) 
K57 
n (%) 
Others 
n (%) 
Total 
n (%) 
 
P 
Healthy children 1 (6) 1  (6) 1 (6) 1 (6) 1 (6) 1 (6) 10 (64) 16 (100)  
0.500 
Healthy adults 0 (0) 5 (13) 3 (8) 2 (5) 0 (0)   1 (3) 27 (71) 38 (100)   
0.235 
Pneumonic  adults 0 (0)  5 (24) 4 (19) 0 (0)    1 (5) 0 (0)  11 (52) 21(100)  
 
 
There was also no significant difference between isolates from healthy and from 
pneumonic adults with regard to capsular types, and the presence of rmpA, and wcaG. 
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Isolates from healthy children differed from healthy adults with regard to the presence of 
wcaG (p=0.006, Table 2 and 3). 
 
Table 3. Virulence factors rmpA and wcaG  in K. pneumoniae isolated  from healthy children, healthy 
adults, and pneumonic adults 
 
 
 
DISCUSSION 
 
K. pneumoniae subsp. pneumoniae  comprises strains with diversities in colony 
morphology, biochemical characteristics, antimicrobial susceptibility and virulence.  
Hypermucoviscosity is a marker of virulence and is associated with invasive diseases such 
as sepsis, pyogenic liver abscesses, and metastatic infections in previously healthy adults. 
Capsular types K1, K2, K5, K20, K54, K57 are also associated with virulence, and are 
frequently isolated from invasive diseases including pneumonia, urinary tract infection, 
liver abscess, and sepsis. Other virulence factors, such as rmpA  and wcaG seem to be 
involved in the ability of K. pneumoniae to evade phagocytosis by leukocytes. rmpA is a 
regulator of mucoid phenotype,  while wcaG converts mannose to fucose to produce a 
thicker capsule [6]. 
Our study showed that K. pneumoniae strains isolated from adults, both the healthy 
and the pneumonic, more frequently carried those virulence determinants. K1, however, 
was not found in any of these strains. Strains isolated from healthy and pneumonic adults 
were highly similar with regard to hypermucoviscosity, capsular types, and the presence 
of the rmpA and wcaG genes. In contrast, strains from healthy children differed from 
those from healthy adults in the hypermucoviscous characteristic and the presence of 
wcaG. These findings pose the question whether strains from healthy and pneumonic 
adults are from closely related clones whereas strains from children are from different 
genetic backgrounds. Other tests to reveal the clonality differences among  K. pneumoniae 
strains isolated from each subgroup (strains from healthy children, healty adults, and 
pneumonic adults) in this study remain to be performed, however. 
 rmpA + rmpA - Total P  wcaG + wcaG - Total P 
 n (%) n (%) n (%)   n (%) n (%) n (%)  
Healthy children 2 (12) 14 (88) 16 (100)   0 (0) 16 (100) 16 (100)  
     0.71     0.00 
Healthy adults 8 (21) 30 (79) 38 (100)   15 (39) 23 (61) 38 (100)  
     1.00     0.075 
Pneumonic adults 5 (24%) 16 (76%) 21 (100)   3 (14) 18 (86) 21 (100)  
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The antimicrobial susceptibility patterns did not differ among the three subgroup 
strains. The pattern was similar to a previous study from Indonesia, where only few 
acquired resistance was found among enteric bacilli isolated from healthy people living in 
the community [7]. 
The role of nasopharyngeal colonization by K. pneumoniae in the development of CAP 
has not been understood yet. Many studies confirmed the role of S. pneumoniae 
colonization in the development of pneumococcal diseases in the community [8]  but no 
study so far has been performed to find the correlation between K. pneumoniae 
colonization and infection in the community. For hospitalized patients, such correlation is 
suggested from reports on multidrug-resistant K. pneumonia [9,10].  We suggest that 
healthy adults in our study population are at a higher risk to develop infections by K. 
pneumoniae, compared to children since adults were colonized more frequently, and by 
more virulent strains. 
 
 
CONCLUSIONS 
 
K. pneumoniae strains isolated from  healthy adults and adults with CAP are highly similar 
in characteristics, and different from those from healthy children. More studies are 
needed to delineate the clonality of K. pneumoniae  and to understand the role of 
colonization by K. pneumoniae in the pathogenesis of infection by this species in the 
community. 
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ABSTRACT 
 
Objective 
Appropriate antibiotic therapy is very important in the management of patients with 
community-acquired pneumonia (CAP). To evaluate the quality of care for CAP patients in 
particular antibiotic management, a qualified instrument is needed. This study aimed to 
develop such an instrument, which is applicable in a middle-income developing country 
setting. 
Methods 
A previous study and Indonesian guidelines were reviewed to derive potential quality of 
care indicators (QIs). An expert panel performed a two-round Delphi consensus procedure 
on the QI’s relevance to patient recovery, reduction of antimicrobial resistance, and cost 
containment. Applicability in practice including reliability, feasibility, and opportunity for 
improvement were determined in a data set of 128 hospitalized CAP patients in 
Semarang, Indonesia. 
Results 
Fifteen QIs were selected by the consensus procedure. Five QIs did not pass feasibility 
criteria, because of inappropriate documentation, inefficient laboratory services, or 
patient factors. Three QIs provided minor opportunity for improvement. Two QIs 
contradicted each other; one of which was considered not valid and excluded. A final set 
of six QIs was defined for use in the Indonesian setting.  
Conclusions 
Using the Delphi method, we defined a list of QIs for assessing the quality of care, in 
particular antibiotic treatment, for CAP in Indonesia. For further improvement, a modified 
Delphi method which includes discussion, a sound medical documentation system, 
improvement of microbiology laboratory services, and multi-center applicability tests are 
needed to develop a valid and applicable QI list for the Indonesian setting. 
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INTRODUCTION 
 
Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality, 
and an economic burden. In low-to middle-income countries, it is one of the most 
important causes of death [1]. A study done in Semarang, Indonesia, during 2007-2009 
showed a high overall mortality of 30% in patients hospitalized with CAP, increasing from 
17% in non-severe to 70% in severe CAP (personal data, unpublished). The mortality in 
this study was much higher than in other studies in Southeast Asia [2,3], indicating that 
the quality of patient care needs evaluation.  
Appropriate antibiotic therapy is one of the most important elements in the 
management of CAP [4]. To evaluate the quality of care for CAP patients and to give 
health care professionals feedback, in particular regarding antibiotic management, a 
qualified instrument is needed. Such an instrument must contain validated quality 
indicators (QIs), have good feasibility and reliability, and provide opportunities for 
improvement. This instrument can initiate intervention programs to improve the quality 
of care of patients with CAP [5] . 
If possible, QIs should be based on scientific evidence such as rigorously conducted 
(trial based) empirical studies [6]. However, like in many fields of medicine, the scientific 
basis for strong recommendations on antibiotic treatment in CAP, i.e. based on 
randomized controlled trials (RCTs), is limited. For some aspects of treatment, e.g. 
comparing early and late of antibiotic administration, RCTs are considered unethical [7]. 
Therefore, as substitution for development of valid QIs in case of insufficient, absent, or 
methodologically weak evidence, a systematic procedure that combines the available 
evidence and expert opinion should be used (Rubin et al., 2001). A method of combining 
evidence and expert opinion is the Delphi method [8]. Using this method, a large group of 
experts can be consulted in several rounds with feedback of the results between rounds.  
This study aimed to develop a list of QIs for assessing the quality of care, especially 
antibiotic treatment, for patients with CAP which is applicable in Indonesia, a middle-
income country, by adapting the methods applied in a previous study in a developed 
country [4]. 
 
 
METHODS  
 
Development of the list of quality indicators 
A list of potential QIs describing the process of care for CAP patients was made up 
from a previous study [4], and an Indonesian national guideline [9] which is mainly based 
on international guidelines with some local contents in 2007. Levels of evidence as 
described by Guyatt et al. (1995) were assigned to indicators derived from the Indonesian 
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guideline by three investigators (KL, MK, MHG) using literatures obtained from a search in 
PubMed using the MeSH term [quality indicators] and [pneumonia]. Since there was no 
MeSH term for "community acquired pneumonia", the complete term was used to narrow 
down the search a little bit more. To specify more, the search terms "treatment" and 
"diagnosis" were added. Literature search was not done for indicators derived from the 
previous study as this has been systematically performed [4].  
 
Rating and adding procedure by expert panel 
The list was presented as a questionnaire to a panel of eighteen specialists from 
different fields of medicine (ten internists, three internist-pulmonologists, two 
pharmacists, three clinical microbiologists) working in four different hospitals in 
Semarang, Indonesia. Using the Delphi method, in a two-round consensus procedure, the 
panel judged the potential indicators on (1) relevance for clinical recovery of the patient, 
(2) relevance for reduction of antimicrobial resistance, and (3) relevance for cost-
effectiveness. A five-category Likert-scale was used that ranged from “completely agree” 
(category 1) to “completely disagree” (category 5). An extra answer category could be 
marked if the experts could not decide about a particular question.  
In the first round, the experts had the opportunity to comment on the proposed 
indicators and to add or modify potential indicators for evaluation. An indicator was 
selected if  >70% of the experts scored 1 (‘completely agree) or 2 (‘agree’). An indicator 
was rejected if > 70% of the experts scored 4 (‘disagree’) or 5 (‘completely disagree’). 
Indicators which did not meet these criteria were reevaluated in the second round using 
the same criteria as applied in the first round, together with indicators added or modified 
by the experts during the first round [10]. Indicators that had met the selection and 
rejection criteria were also re-assessed in the second round to provide opportunity for the 
experts if they wanted to change their rating. This process could be repeated several 
times in order to achieve agreement for selection or rejection of all the proposed 
indicators among the experts. An indicator that still did not meet the selection or rejection 
criteria after several rounds will be removed as it is an indication that the indicator is weak 
or of low value. 
 The evidence level of  indicators  added by the experts during the concensus rounds 
were also assessed based on a search in PubMed. An indicator was considered not valid 
and excluded if contradictory evidence was identified. 
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Figure 1. Flowchart showing the steps in the development of quality indicators (QIs) for assessing 
and improving the quality of care related to antibiotic use in patients with community-
acquired pneumonia in Semarang, Indonesia. 
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Assessment of applicability of quality indicators in a specific patient sample 
Study setting, population and data collection. Due to limited resource, the applicability 
study could only be done in 2012-2013. Data were retrieved retrospectively from all 128 
medical files of patients involved in a CAP study from 2007-2009 in Dr. Kariadi Hospital, a 
university hospital in Semarang, Indonesia. Information was retrieved from admission 
sheets, medical and nursing records, and medication charts. Two reviewers (AR and AA) 
worked together to collect all the data and recorded them on printed standardized forms, 
then entered these data into one database.  
Reliability. To test the inter-observer reliability of the data collection, 15 (11%) of the 128 
patient medical files were randomly chosen. An independent group of two reviewers (HF 
and MHG) recorded the data from these files together on the same standardized forms. 
Inter-observer reliability was calculated as Kappa (κ) scores. Scores of 0.41≤ κ ≤ 0,6 were 
considered to be moderate, 0.61≤ κ ≤0.8 good, and κ >0.8 very good. Scores of κ <0.4 
were considered to be poor and led to elimination of the indicator (Landis and Koch, 
1977). 
Feasibility. Feasibility of data collection was defined as the percentage of missing values 
per indicator (i.e. the percentage of indicator values that could not be calculated because 
≥1 element of the algorithm could not be retrieved from the available records). Indicators 
with feasibility >25% (meaning that > 25% of the data were missing) were considered 
having poor feasibility and not selected (Schouten et al., 2005) 
Performance score. The performance score is the rate of compliance toward a QI, which 
must be low enough to give the opportunity for improvement (Rubin et al., 2001). If the 
performance score for a QI is ≥85% (meaning the compliance is already high), the 
indicator is less sensitive to change or to make improvement, thus, not selected. 
 
 
RESULTS 
  
Development of the set of quality indicators 
The process of the development of the list of QIs is summarized in Figure 1. Twelve QIs, 
nine derived from a Dutch study [4] and three from the Indonesian guideline, were 
presented to the expert panel. Seven new indicators were added by the panel. After the 
two round-consensus procedure three QIs were rejected: one (‘urinary antigen test for 
Legionella spp upon clinical suspicion’) because the tests were not available in Indonesia, 
one (‘initiation of antibiotic treatment within 8 hours’) because the experts thought that 
initiating antibiotic within four hours was better than eight hours, and one (‘empirical 
antibiotic regimen according to local guidelines’) because not all hospitals had a local 
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guideline. Two indicators, ‘change broad-spectrum empirical into pathogen-directed 
therapy (streamlining)’ and ‘change empirical therapy according to culture if the patient 
does not improve or worsens after 24-72 hours of empirical therapy’, were combined into 
one indicator: ‘change broad-spectrum empirical into pathogen-directed antibiotic 
therapy (streamlining) once the culture result is available’. 
The result was a final list of fifteen QIs (Table 1).  
 
Assessment of the applicability of the QIs  
The reliability, feasibility, and performance score of the fifteen QIs were presented in 
Table 1.   
 
Reliability. No indicator was rejected because of poor reliability (Table 1). One indicator 
scored κ= 0.412 which means a moderate inter-observer reliability (‘stop antibiotic 
therapy after three consecutive days of defervescence’). All other indicators scored κ>0.6.  
Feasibility. Five QIs did not pass feasibility criteria: ‘transport sputum sample to the 
laboratory within 4 hours’, ‘obtain blood samples for culture from the left and the right 
arm’, ‘change broad-spectrum empirical into pathogen-directed therapy (streamlining) 
once culture result available’, ‘calculate unit cost’ and ‘evaluate albumin level before 
starting antibiotic treatment’ (Table 1). For the QI ‘evaluate albumin level before starting 
antibiotic treatment’, feasibility was 100% because we were unable to make the indicator 
measurable. Although the time at which the albumin level is issued by the laboratory and 
time at which the antibiotic was started were usually recorded, we could not make sure 
that the doctors did evaluate the albumin level before starting the antibiotic. We could 
not rule out the possibility that the doctors order the albumin test for other purpose.  For 
the other four QIs feasibility was poor because many data could not be retrieved from the 
medical records. 
Performance score. Three QIs did not appear to provide opportunity for improvement, 
these are ‘empirical antibiotic regimen according to national guidelines’, ‘adapt dose and 
dose interval of antibiotics to renal function’, and ‘make an X-ray at the emergency 
department’ (Table 1). 
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To summarize, seven QIs met all criteria for reliability (κ >0.4), feasibility (data missing 
<25%) and performance (<85%), indicating their applicability in (local) practice in 
Indonesia. These QIs are ‘take two sets of blood samples for culture’, ‘obtain sputum 
samples for Gram stain and culture’, ‘obtain sputum sample and start antibiotic therapy in 
the emergency department’, ‘timely initiation of antibiotic therapy within four hours after 
presentation’, ‘switching from iv to oral therapy when clinically stable’, ‘stop antibiotic 
therapy after three consecutive days of defervescence’, and ‘length of therapy is five days 
for uncomplicated CAP (CURB score < 2)’.  
Though meeting all the applicability criteria, one QI (‘stop antibiotic therapy after 
three consecutive days of defervescence’) was judged not valid leaving a final set of six 
QIs. 
 
 
DISCUSSION 
 
Using the Delphi method, we defined a list of QIs for assessing the quality of care, in 
particular antibiotic treatment, for patients with CAP in Indonesia. To our knowledge, this 
is the first study to develop QIs in Indonesia by using a scientifically sound method.  
A two-round consensus procedure involving eighteen experts resulted in 15 QIs. In the 
applicability assessment in a specific Indonesian setting, five QIs were rejected because of 
poor feasibility. This was partly caused by the quality of medical records and the 
documentation of test results. Specific strategies need to be implemented to improve 
medical data documentation, so that important QIs will not be rejected solely based on 
the lack of data. The strategies range from relatively simple adjustments, such as 
simplifying and standardizing the format of the paper medical records, to a more 
complicated introduction of an electronic medical record system.  
The absence of health insurance, or limited coverage of health insurance for diagnostic 
tests also determined the feasibility of data collection, as this was quite often the reason 
not to perform the recommended diagnostic tests, thereby limiting the availability of 
culture related data. Feasibility could also be poor as many doctors felt that the expensive 
cultures was of limited clinical value, for instance, patients had improved by the empirical 
antibiotic therapy, or the culture results frequently came too late: by the time the results 
came, the patient had already died or been discharged. Doctors also felt that the culture 
results were frequently difficult to interprete, in particular when the result was ‘sterile’, 
contaminant, or an uncommon respiratory pathogen. To improve the feasibility of the 
related QIs, microbiology laboratories need to improve their services, by shortening the 
turnaround time, and providing early and frequent clinical consultation to the clinicians. 
Other causes of poor feasibility came from specific patient factors. Sputum cultures 
could not be obtained when patients were unable to produce sputum because of severe 
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CAP or of non-productive type cough, thereby, no data could be retrieved from the 
medical records to calculate the applicability. The proportion of patients with such specific 
factors may differ among different hospitals in different areas, underlining the importance 
of external validation of the QIs.    
Three indicators were rejected because of providing minor opportunity for 
improvement. The indicator ‘empirical antibiotic regimen according to national guidelines’ 
achieved high performance since ceftriaxone, which is recommended by the national 
guideline as one of the first choices (aside β-lactam antibiotics + β-lactamase inhibitors), 
was cheap, covered by all available health insurance types,  and had a relatively good 
susceptibility profile compared to other antibiotics. Therefore, ceftriaxone had already 
become the first choice for most infectious diseases including CAP in the studied hospital. 
Since ceftriaxone in routine dosing is safe for any kidney function level, the indicator 
‘appropriate dose and dose interval of antibiotic with regard to renal function’ 
automatically achieved high performance. The indicator ‘make an X-ray at the emergency 
department’ was rejected because of high performance, possibly because the study was 
performed in an academic hospital that might not represent non-academic hospitals. A 
multicenter study is needed to increase generalizability of this QI list, as the performance 
may be lower in non-academic hospitals.  
Two QIs appeared to contradict each other: ‘length of therapy is five days for 
uncomplicated CAP (CURB score < 2)’ which has a A2 level evidence [24,25], and ‘stop 
antibiotic therapy after three consecutive days of defervescence’ which was derived from 
expert opinion in a previous study (Schouten et al., 2005). The latter QI was accepted by 
the previous study because of  no contradictory evidence in the year of the study (2005) 
and of its good applicability. However, we found that subsequent studies in 2006 have 
already used different parameters to make a decision to stop antibiotic, including fever, 
respiratory symptoms like dyspnea, coughing, and sputum production which are 
important clinical signs of CAP. Therefore, the decision to stop antibiotic therapy should 
rely not only on fever defervescence, but also on the improvement of respiratory 
symptoms and the general condition of the patient [26-28]. Thus, the indicator ‘stop 
antibiotic therapy after three consecutive days of defervescence’ had been not valid at the 
time of the Delphi rounds implementation, that should be removed despite it’s good 
applicability.  
Contradiction between indicators in the QI list might come from the design of the 
Delphi method, in which each expert scored the questionnaires independently. The 
experts might have different perceptions on a proposed indicator because they consider 
different definitions, different patient groups, or different work conditions, which were 
specific for a particular expert but not generally applicable. The absence of a group 
discussion in Delphi method might raise the possibility of mis-perception between the 
experts with the observers who prepared, collected and analyzed the questionnaires rated 
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CAP or of non-productive type cough, thereby, no data could be retrieved from the 
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by the experts. This might happen with the indicators ‘Evaluate albumin level before 
starting antibiotic treatment’ and ‘Calculate unit cost’, for which the observers were 
unable to make them measurable. In addition, without a group discussion, the observers 
might miss the points why the experts agree or disagree or proposed specific indicators, 
which might not just include a scientific judgment, but also a local consideration. For 
instance, the QI ‘Timely initiation of antibiotic therapy (within 4 h after presentation)’ 
should have been removed since a stronger evidence published in 2005 [29] showed that 
early antibiotic therapy did not reduce mortality. However, this QI might also be kept 
when in the local setting, delayed giving antibiotic is common; thereby it is included as an 
indicator of care [30]. A modified Delphi method, such as the RAND method, which 
includes a group discussion between the consensus rounds, might be implemented to 
diminish the problems of contradiction or different perception [31].  
The changing of validity status of an indicator from time to time, as happened with the 
indicator ‘stop antibiotic therapy after three consecutive days of defervescence’ 
underlines  the necessity to always check its validity even after only few years of 
publication. 
To keep in mind, methods for determining the quality of care of patients with CAP 
have also been developed by several other institutions [4,7]. The resulted QIs might differ 
in some points because of the difference in setting. For instance, there is no necessity to 
use ‘give antibiotic according to the guideline’ or ‘appropriate dose and dose interval of 
antibiotic with regard to renal function’ as a QI when the antibiotic is the first choice for 
most infectious diseases in this setting and does not need to be adjusted according to 
renal function. When a QI is invariably high with little inter-hospital variation, it becomes 
insensitive and less succesfull as an indicator for quality improvement [4], as the main goal 
of our list of QIs was to prioritize the indicators most needed for improvement of the 
patient care. In other hand, additional QIs might be proposed by local experts to improve 
problems which are specific to their setting. In our study, the experts added several QIs 
related to blood and sputum cultures (‘Obtain blood samples for culture from the left and 
the right arm’ or ‘Transport sputum sample to the laboratory within 4 h’, and ‘Obtain 
sputum sample and start antibiotic therapy in the emergency department’), implying their 
hope to improve the problem of low clinical value of the cultures from contamination and 
failure to grow the important pathogens.   
The use of valid and applicable QIs for CAP patients in Indonesia is emphasized by the 
fact that CAP is an important cause of mortality in this country. In addition, with the new 
Indonesian government policy to provide a national health insurance for all residents in 
Indonesia (BPJS Health Care/JKN) since January 2014 [32], it is urgent to implement 
approriate QIs, as a measure to control the quality of health care and cost efficacy. Once 
implemented, the implication on health care and patient outcome need to be re-studied, 
as part of continuing improvement in the national health care system. 
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CONCLUSIONS 
 
This study provides a basis for further investigations for the development of a sound, valid 
set of QIs for the management of CAP in Indonesia. To improve the development of  the 
QI list, a modified Delphi method which includes a discussion session may be more 
appropriate in the Indonesian setting. To improve the feasibility of the QIs, it is 
recommended that hospitals use a solid and sound medical record system and improve 
the services of microbiology laboratories to increase the clinical value of cultures. An 
external validation is needed to assess the generalizability of the QIs.  
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Appendix 1. Supporting evidence level (Guyatt GH, 1995) 
 
Evidence 
level 
  Definition Example of a study providing 
the specified level of evidence 
A1 A good systematic review of studies designed to 
answer the question of interest 
Systematic review of randomized, 
controlled trials 
A2 One or more rigorous studies designed to answer 
the question but not formally combined 
Randomized, controlled trial 
B One or more prospective clinical studies that 
illuminate but do not rigorously answer the 
question 
Prospective cohort study; underpowered or 
poor quality randomized controlled trial; 
nonrandomized, controlled trial 
C One or more retrospective clinical studies that 
illuminate but do not rigorously answer the 
question 
Audit or retrospective case-control study 
D Formal combination of expert views or other 
information 
Delphi study; expert opinion; informal 
consensus 
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INTRODUCTION 
 
In this thesis, we have studied the etiology and management of community-acquired 
pneumonia (CAP) in Indonesia in patients that were admitted to  hospital, the 
characteristics of major respiratory pathogens carried by healthy individuals, the risk 
factors of carriage, and the differences between isolates from healthy individuals and 
those from patients with CAP. The development of a valid and applicable list of quality 
indicators (QIs) as a tool to evaluate the quality of care of CAP patients in Indonesia is 
described as well. 
In this chapter, the main findings are summarized and discussed on the basis of the 
four research questions posed in chapter 1 of this thesis. Furthermore, recommendations 
for patient care  and suggestions for further research  on the different topics are 
presented. 
 
 
RESEARCH QUESTION 1 – THE ETIOLOGY OF CAP 
 
What are the pathogens causing CAP in Indonesia? What is the frequency of antimicrobial 
resistance of clinical isolates of CAP in Indonesia? Is there an association between etiology 
and the underlying diseases, severity of disease, and mortality ? 
 
From October 2007 until April 2009, 148 adult patients who were admitted to two 
hospitals in Semarang because of CAP were included in the study. Employing a wide range 
of the most advanced microbiological tests we found that influenza A and B viruses were 
the most common (18%) cause of CAP, either as single or co-pathogen, followed by 
Klebsiella pneumoniae (14%) and Streptococcus pneumoniae (13.5%). The next 
commonest pathogens (approximately 5% in incidence each) were Mycobacterium 
tuberculosis, Chlamydia pneumoniae, and other Gram-negative bacilli (GNB) including 
Enterobacter cloacae, Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and 
Burkholderia cepacia. However, K. pneumoniae and other GNB together (19%) surpassed 
the incidence rate of influenza infection. Almost all bacterial pathogens had wild type 
susceptibility profiles, indicating that they remained susceptible to early generation 
antibiotics. The study also found that the crude 30-days mortality was very high (30%). 
The etiology did not relate to the underlying diseases, nor predicted the severity or 
mortality of CAP; however, the severity of CAP at the time of admission was predictive of 
mortality in this cohort of patients.  
This study shows that the pattern of pathogens causing CAP in Indonesia is different 
from that in countries in North America, European countries, and Australia. The etiology 
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pattern found in this study is closer to the pattern previously observed in neighboring 
countries [1-4]. Therefore, a guideline  for the management of CAP construed and 
implemented in North America, Europe, or Australia might not be appropriate in 
Indonesia. Multicenter CAP studies including viral diagnostics should be carried out in 
other cities in Indonesia or even in Southeast Asia  to delineate the full spectrum of 
etiological agents in this region and, thus, yield the necessary information to develop or 
improve local guidelines for the management of CAP. An antibiotic which covers K. 
pneumoniae and other Gram-negative aerobic bacilli should be included in the empirical 
regimens for CAP in Indonesia. Because these bacterial agents still have wild type 
antibiotic susceptibility profiles, earlier generation antibiotics, for instance ampicillin-
sulbactam or amoxicillin-clavulanate, would be the most appropriate choice, thereby 
avoiding the selection pressure exerted by newer generations and broad-spectrum 
antibiotics, especially third-generation cephalosporins and carbapenems [5]. Also, 
inclusion of an antiviral agent such as oseltamivir to treat influenza virus infection should 
be considered as part of an empirical regimen, especially in cases of severe CAP requiring 
intensive care. Our findings also unequivocally support seasonal influenza vaccination for 
risk groups to prevent severe CAP and CAP mortality due to influenza in Indonesia as has 
been implemented in many other countries [6,7]. 
The use of PCR is instrumental to detect viruses, particularly in an epidemiological 
study, though it might still be too expensive for routine patient care. However, 
implementation of PCR-based detection of influenza viruses in throat or sputum samples 
would be a highly desirable additional routine test in this area of the world. Alternatively, 
for centers without PCR facilities rapid immunochromatographic lateral flow and 
membrane-based immunoassays are available that have ± 90% predictive values at the 
prevalences of influenza found in the clinical setting of CAP admission in Indonesian 
hospitals [8]. 
Optimal bacteriological diagnostics are required to be able to adapt the initial therapy, 
including alternative tests for detecting S. pneumoniae such as antigen tests [9,10]. The 
implementation of accurate and rapid diagnostic procedures at patient’s presentation 
should be prioritized, particularly in cases of severe CAP since establishing an etiological 
diagnosis is likely to improve outcomes [11]. 
Leptospirosis is a zoonotic disease that is endemic in Indonesia. The clinical 
manifestations are variable. Patients may not be icteric and initial presentation may 
resemble pneumonia. Indeed, in our study, we found four cases fulfilling the clinical 
criteria of CAP and having a positive Leptospira spp PCR on throat and serum. In this area 
of the world, Leptospira spp should be in the differential diagnosis of CAP in particular 
when the patient is of the risk group, and appropriate diagnostics should be performed. 
The possibility of a Leptospira spp PCR on throat swab as a non-invasive diagnostic test for 
leptospirosis needs further study.  
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RESEARCH QUESTION 2 – NASOPHARYNGEAL CARRIAGE OF RESPIRATORY BACTERIAL 
PATHOGENS   
 
What is the frequency of nasopharyngeal carriage of the most common bacterial 
pathogens in the respiratory tract of healthy people in Indonesia? What is the frequency of 
antimicrobial resistance of strains carried by healthy individuals? What are the risk factors 
for throat carriage of the major bacterial respiratory pathogens? 
We studied the nasopharyngeal carriage of S. pneumoniae, K. pneumoniae, and other 
GNB in a population-based survey among healthy inhabitants of Semarang city. A total of 
496 subjects were included. In healthy adults aged 45-70 years old, the carriage rate of 
GNB was surprisingly high (34%), exceeding that of S. pneumoniae (11%). In adults, K. 
pneumoniae was the single most common (15%) GNB species isolated from the 
nasopharynx, while in children K. pneumoniae and Pseudomonas spp. were the most 
common ones (7% each).  The carriage rate of GNB other than K. pneumoniae, such as E. 
coli, Enterobacter spp., Pseudomonas spp., A. baumannii complex, was 19% in adults and 
20% in children. The nasopharyngeal carriage rate of GNB in the community in Europe, 
North America, and Brazil was reported to be much lower, 1-6% [12,13]. High GNB 
carriage rates are usually related to specific conditions, such as preceding antibiotic 
therapy, underlying diseases or long hospital stay [14]. In our study, high GNB carriage 
rates were related partly to poor water and food hygiene, corresponding to reports by 
others that GNB are frequent contaminants in water and foods in this part of the world 
[15-17]. The antimicrobial susceptibility profile of K. pneumoniae and other 
Enterobacteriaceae showed low prevalence of resistance to early generation of 
antibiotics. Since the throat carriage rate of K. pneumoniae and other GNB is high, the 
finding of these pathogens in sputum culture of pneumonia patients should be 
interpreted carefully, for instance, by assessing the quality of sputum, or performing 
semiquantitative or quantitative cultures. It is also of interest to study whether a 
correlation between carriage and infection by K. pneumoniae or other GNB can be 
established as was shown for S. pneumoniae [18,19].  Studies have reported such a 
correlation in hospital settings [20,21], which suggests that this may happen in the 
community as well. 
The carriage rate of S. pneumoniae was 43% in children 6-60 months old  and 11% in 
adults 45-70 years old. The proportion of subjects carrying S. pneumoniae varied 
significantly across the districts of Semarang, and tended to be higher in the suburban and 
eastern parts of the city. Carriage was associated with being a child, presence of toddlers 
at home and passive smoking. The prevalence of S. pneumoniae with reduced 
susceptibility to penicillin and co-trimoxazole was high. However, the national and local 
guidelines for empirical antibiotics for CAP in children still recommend these two 
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antibiotics as the first choices [22], while those for meningitis still recommend ampicillin 
for the second line [23].      
The most common capsular serotypes in children, comprising 61% of strains, were 
6A/B, 15B/C, 11A, 23F, 19F, 23A, while those in adults were 6A/B, 15B/C, and 15A, 
comprising 75% of strains. The commercially available 13-valent pneumococcal conjugate 
vacccines (PCV) [24] provided overall only 45% strain coverage for pneumococci isolated 
in the infant and toddler population in this study. However, the coverage varied among 
districts, from 13 to 100%. The coverage of this vaccine  in other Southeast Asian countries 
is higher (63%-97%) [25], implying the need to perform  a nationwide epidemiological 
study , in which isolates from both invasive disease and carriage should be included.  
 
 
RESEARCH QUESTION 3 – BACTERIAL PATHOGEN CARRIAGE VERSUS INFECTION 
 
What are the characteristic differences between bacterial respiratory pathogens isolated 
from colonized but otherwise healthy individuals versus those obtained from infected 
individuals? 
 
The characteristics of K. pneumoniae strains from healthy children, healthy adults, and 
adults with CAP  were compared, regarding the  antimicrobial susceptibility profile, 
hypermucoviscosity phenotype, capsular types, the presence of known virulence factors 
rmpA (regulator of mucoid phenotype) and wcaG (a gene which encodes the conversion 
of mannose to fucose to produce a thicker capsule). These two genes provide Klebsiella 
capsules that protect them from phagocytosis by neutrophils [26]. K. pneumoniae strains 
isolated from children differed significantly  from those isolated from healthy adults, i.e, 
they rarely expressed the hypermucoviscous phenotype, and had no wcaG gene. In 
contrast, strains from healthy adults and adult CAP patients were highly similar with 
regard to hypermucoviscosity, capsular types, and the presence of rmpA and wcaG genes, 
indicating that they come from closely related clones. We suggest that healthy adults in 
our study population are at a higher risk to develop infections by K. pneumoniae, 
compared to children since adults were colonized more frequently, and by more virulent 
strains.  
The characteristics of S. pneumoniae from healthy and infected individuals could not 
be compared in our study, since not enough S. pneumoniae strains could be isolated from 
the infected individuals (CAP patients) to make a valid comparison.  
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RESEARCH QUESTION 4 – QUALITY INDICATORS FOR MANAGEMENT OF PATIENTS  
 WITH CAP 
 
How should the management of patients with CAP be evaluated? What are the results of 
such an evaluation in an Indonesian hospital? 
 
The mortality rate in CAP patients in our study was much higher than that in other 
studies in Southeast Asia [2,9,27] , indicating that the quality of patient care may need 
closer evaluation. Ready access to health care is one potential issue. However, once 
presented to health care with CAP, appropriate antibiotic therapy is one of the most 
important elements in the management of CAP patients [28]. To evaluate the quality of 
care for CAP patients and to  provide health care professionals with feedback on their 
antibiotic management, a qualified instrument is needed. Such an instrument must 
contain validated quality indicators (QIs), have good feasibility and reliability, and provide 
opportunities for improvement. Such an instrument can be developed by  a systematic 
procedure that combines scientific evidence and expert opinion [29], like the Delphi 
method offers. Using this method, we developed a list of 15 indicators by a two-round 
consensus procedure. The applicability in terms of reliability, feasibility, and opportunity 
for improvement of these QIs was assessed by retrieving 128 medical files of patients 
hospitalized for CAP from 2007-2009 in Dr. Kariadi hospital, Semarang, Indonesia.  
The reliability of  the QIs  was moderate or good. Five indicators did not pass feasibility 
criteria, either because of inappropriate medical data documentation, insufficient 
microbiology laboratory services, or patient factors. Three QIs provided little opportunity 
for improvement. Two out of the remaining seven indicators contradicted each other, one 
of which was found to be no longer valid according to recent evidence. A final set of six 
indicators was defined for use in the Indonesian setting. These included ‘take two sets of 
blood samples for culture’, ‘obtain sputum samples for Gram stain and culture’, ‘obtain 
sputum sample and start antibiotic therapy in the emergency department’, ‘timely 
initiation of antibiotic therapy within four hours after presentation’, ‘switching from iv to 
oral therapy when clinically stable’, and ‘length of therapy is five days for uncomplicated 
CAP (CURB score < 2)’. This list of QIs is proven to be valid and applicable in Indonesian 
hospitals, in particular of class A and B which are equipped with microbiology services, to 
evaluate the quality of care in the management of CAP. Use of this list in such hospitals 
and the subsequent evaluation of the findings will provide information needed to improve 
the quality of care in the hospital, in particular which relevant to the QIs. The application 
of this list will also give information on the generalisability of this QI list.   
Our study also provides a basis for the development of valid sets of QIs for the 
management of patients with other important medical problems in hospitals in Indonesia 
in order to improve health care in Indonesia in general.  
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A problem with using the Delphi method as we did, is the absence of a meeting of the 
participants. This meeting was absent to keep the experts’ independence in rating the 
proposed indicators,  but might leave different views about the indicators unnoticed and 
undiscussed by the experts and the observers who prepared, collected and analyzed the 
questionnaires rated by the experts. The consequences were:  some QIs could not be 
operationalized by the observers and some QIs contradicted each other.  To avoid this, we 
suggest to implement a modified Delphi method, such as the RAND/UCLA 
Appropriateness method, a method to synthesize the scientific literature and expert 
opinion on health care topics which includes a discussion between consensus rounds, but 
still allows the experts to rate the proposed indicators independently and anonymously 
[30].  
 To increase the feasibility so that no important indicators are rejected solely because 
of lack of data, more standardized medical documentation systems need to be 
implemented. In addition, clinical microbiology laboratories should provide early and 
frequent clinical consultation to clinical wards, so that clinicians are willing to order 
cultures, thus, increasing the feasibility of using those indicators that rely on culture 
results. 
The development and implementation of QIs  for the care of CAP patients and patients 
with other  medical problems in Indonesia is especially urgent because since January 2014 
the Indonesian government has implemented a new policy which provides all Indonesian 
citizens with health insurance [31]. The use of valid and generally applicable QIs will help 
to maintain the highest standard of care and control the costs. 
  
RECOMMENDATIONS FOR PATIENT CARE 
To optimize the outcome of patients and prevent problems of antimicrobial resistance 
in patients hospitalized with CAP, it is important to perform all diagnostic procedures 
early, i.e., on the day of admission. The provision of facilities to do culture at the 
emergency department might stimulate doctors to take culture before initiating 
antibiotics. This is particularly important for those patients that are admitted to hospitals 
for severe disease, so that the etiology of CAP in this group is established at a time when 
its management can still be adjusted to improve outcomes. Laboratories of Clinical 
Microbiology should also institute appropriate standards of services, provide valid and 
rapid tests for common pathogens, reduce the turnaround time, and give early and 
frequent clinical consultations to their fellow clinicians in the hospital wards. By this 
means, the results of microbiology tests will contribute to better patient outcomes and 
control the problems of antimicrobial resistance, and hence, increase the compliance of 
doctors to perform the relevant microbiological diagnostics for their patients. 
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Consequently, a more comprehensive set of valid and applicable quality indicators for the 
improvement and control of patient care can be developed.  
The types of microbiology tests provided should refer to the prevailing etiologies of 
CAP in the area, which is derived from qualified epidemiological studies. Alternative tests 
for S. pneumoniae (such as PCR and urinary antigen test), C. pneumoniae (PCR, serology), 
and tests for influenza viruses (PCR, rapid test, serology) are some of the recommended 
tests (Table 1).  
Since K. pneumoniae, other GNB and S. pneumoniae are commonly found in the 
nasopharynx of healthy individuals, specific measures to distinguish infection from  
carriage or colonization should be routinely performed. These include the assessment of 
sputum quality, the coherence between microscopy and cultures, and performing 
semiquantitative or quantitative cultures. 
For L. pneumophila, given the incidence was low (only 1 case was detected), we do not 
recommend the tests for routine patient care. However, Legionella longbeacheae is 
probably an agent that needs to be tested in a future epidemiology study, provided the 
reports on its incidence in Southeast Asia are increasing [32,33]. 
 
 
Table 1. Microbiological tests to be provided by Indonesian hospitals (Class A and B) for evaluation 
of patients hospitalized for CAP 
Pathogen  Routine diagnotics Advanced diagnostics 
Influenza A/ B virus Specimens  : throat swab OR 
nasopharyngeal swab/ aspirate 
Methods   : rapid lateral flow and 
membrane-based 
immunoassays  
 Specimens:  throat swab OR 
nasopharyngeal 
swab/aspirate, OR 
bronchial wash OR 
endotracheal aspirate OR 
sputum 
 Methods     : real-time PCR 
K. pneumoniae and 
other GNB 
Specimens : blood AND sputum OR 
endotracheal aspirate 
Methods: 
     Sputum or endotracheal aspirate:  Gram-
stain AND semi-
quantitative/quantitative 
culture on elective and/or 
selective solid agar media (e.g. 
McConkey) 
      Blood   :  commercial broth-based media 
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Pathogen  Routine diagnotics Advanced diagnostics 
S. pneumoniae Specimens : blood AND urine AND sputum 
OR endotracheal aspirate 
Methods:  
    Sputum OR  endotracheal aspirate:  
                    Gram-stain and semiquan-
titative OR quantitative 
cultures on selective blood 
containing agar  
     Urine   : commercial rapid 
immunochromatograhic  
assay 
Blood       :  commercial broth-based 
media 
Specimens : sputum OR endotracheal 
aspirate 
Methods   :  real-time PCR  
C. pneumoniae  Specimens : serum  
Methods    :  microimmunofluores-cence 
Specimens : sputum OR endo-tracheal 
aspirates 
Methods    : real- time PCR 
M. tuberculosis Specimens : sputum OR other respiratory 
samples 
Methods    : Acid-fast staining (Ziehl-Neelsen 
OR, better, Auramine) 
Specimens : sputum OR other 
respiratory samples 
Methods    : conventional culture on 
solid agars OR, better, 
commercial broth-based 
culture (M-GIT),  PCR 
Leptospira spp. Specimens : serum 
Methods    : commercial rapid 
immunochromatographic 
assay 
Specimens : serum OR urine 
Methods    : 
      Serum :  enzyme-linked immuno 
assay (ELISA), microscopic 
aggluti-nation test (MAT) 
      Urine    : real-time PCR 
 
 
The implementation of our quality indicators (QIs) in hospitals in particular of class A 
and B in Indonesia will guide the doctors to select the clinically most useful diagnostic and 
therapy measures, thus improve patient care. Since the Indonesian government has been 
instituting the new policy of national health insurance, the development and 
implementation of such QIs is urgent as a measure to control the quality of care and 
prevent excess costs.  
 Although early initiation of antibiotic treatment (within 4 or 8 hours of admission) is 
no longer proven to reduce mortality, a long delay in initiating antibiotic therapy is an 
unexpected event from the perspective of the quality of care [34]. We assume this is the 
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reason why the experts recommended the QI ‘initiating antibiotic within 4 hours of 
admission’. This will need comprehensive efforts and coordination between doctors, 
emergency room staffs, and the pharmacy department. However, this QI potentially 
causes an increase of inappropriate use of antibiotics in the emergency room [35]. Careful 
evaluation and frequent feedback to the phycicians is needed to achieve the goal of timely 
initial antibiotic therapy without increasing inappropriate antibiotic use [36,37].  
The choice of first line empirical antibiotic therapy for CAP, which according to the 
national Indonesian guideline is ceftriaxone or a combination of a β-lactam with a β-
lactamase inhibitor, needs evaluation. Since ceftriaxone exerts selective pressure for ESBL-
producing GNB [38,39], the emergence and spread of these strains in the hospital should 
be monitored. The new guidelines should be developed to promote prudent antibiotic use 
behaviour among doctors. The best choice of empirical antibiotic therapy for an adult 
patient presenting with CAP requiring hospitalization in this setting would be ampicillin-
sulbactam or amoxicillin-clavulanic acid. These antibiotics cover both K. pneumoniae and 
other GNB and S. pneumoniae, while limiting selective pressure for ESBL [40-42]. 
 
 
RECOMMENDATIONS FOR FURTHER RESEARCH 
Since Indonesia is a large and populous country consisting of 33 provinces with over 
17,000 islands in total, the generalizability of our findings needs to be confirmed in larger, 
preferably multicenter studies. By this means, national and region-specific data are 
provided to inform the development of appropriate guidelines. Such data will also be 
important for the evaluation of the value of the guidelines in improving the quality of care 
and patient outcome.  
Other research to be prioritized is a study of the correlation between nasopharyngeal 
carriage/colonization and infection by K. pneumoniae and other GNB among adults, as has 
been shown with S. pneumoniae [18]. The clonality of pathogens causing CAP also needs 
to be revealed using molecular techniques such as multilocus sequence typing (MLST) or 
whole genome sequencing. This information will improve our understanding on the 
pathogenesis and the transmission pattern of CAP pathogens, thereby directing 
prevention programs. The identification of capsular types from more pathogenic strains of 
K. pneumoniae might have implication for future vaccine development.   
The possibility to develop throat swab PCR as an alternative diagnostic method for CAP 
caused by Leptospira spp. is another interesting topic for further research. The emergence 
and spread of ESBL-producing strains of GNB in the hospital and in the community should 
be monitored as ceftriaxone is routinely used as empiric antibiotic therapy.  
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Community-acquired pneumonia (CAP) is one of the most common infectious diseases 
worldwide. In low-to middle-income countries, it is one of the most important causes of 
mortality and morbidity. The aim of this thesis was to enhance our knowledge on clinical 
and microbiological aspects of CAP in Indonesia. This information is necessary for the 
development of evidence-based guidelines for the management of patients with CAP in 
Indonesia. 
Part I provides background information on CAP in Southeast Asia. Chapter 2 presents 
an overview of peer-reviewed literature on CAP in Southeast Asia from January 2000 to 
December 2011 with focus on the epidemiology, clinical presentation, etiology, risk 
factors, treatment, and outcome. As general conclusion one can state that in this part of 
the world the information on CAP is still lacking as only three Southeast Asian countries 
(Malaysia, Thailand, and Singapore) have published CAP studies. In addition, the research 
methods varied between the three countries that did study CAP, and the used methods 
were not frequently well standardized.  
In part II, we explored the characteristics of CAP patients in two hospitals in Semarang 
city, Central Java, the pathogens causing CAP using up-to-date microbiological diagnostic 
tests, and the outcome of hospitalization. Chapter 3 presents the results of the 
prospective, hospital-based study of 148 CAP patients. The etiological pattern of CAP 
proved to be quite different from that in developed countries in Europe, North America, 
or Australia.  Respiratory viruses were the commonest agents, identified in 45% of the 
patients, with influenza A and B viruses as the most frequently detected (18%). Gram-
negative bacilli (GNB), comprising of Klebsiella pneumoniae (14%) and other GNB (5%), 
were the commonest bacterial cause of CAP in patients admitted with this infection, 
folllowed by Streptococcus pneumoniae (13%). Mixed infections were common. The 
mortality rate among the 148 patients was high (30%) and significantly associated with 
severity, and with failure to establish an etiological diagnosis. Chapter 4 reports 
leptospirosis in five cases of CAP based on several diagnostic tests including a rapid test 
for leptospirosis, serology with enzyme-linked immunosorbent assay (ELISA) and 
microscopic agglutination test (MAT), and polymerase chain reaction (PCR) on acute and 
convalescent sera, urine, sputum samples, and throat swabs. The finding that PCR on 
throat swabs was concordant with the PCR on acute serum samples was of interest, 
raising the possibility to employ throat swabs as alternative non-invasive samples for the 
diagnosis of acute leptospirosis. 
As it is well known that pneumonia is preceded by nasopharyngeal carriage of 
respiratory pathogens, part III explores the carriage rate of S. pneumoniae, K. 
pneumoniae, and other GNB in healthy individuals and compares the characteristics of 
these strains to those isolated from pneumonia patients. Chapter 5 and chapter 6 
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prospective, hospital-based study of 148 CAP patients. The etiological pattern of CAP 
proved to be quite different from that in developed countries in Europe, North America, 
or Australia.  Respiratory viruses were the commonest agents, identified in 45% of the 
patients, with influenza A and B viruses as the most frequently detected (18%). Gram-
negative bacilli (GNB), comprising of Klebsiella pneumoniae (14%) and other GNB (5%), 
were the commonest bacterial cause of CAP in patients admitted with this infection, 
folllowed by Streptococcus pneumoniae (13%). Mixed infections were common. The 
mortality rate among the 148 patients was high (30%) and significantly associated with 
severity, and with failure to establish an etiological diagnosis. Chapter 4 reports 
leptospirosis in five cases of CAP based on several diagnostic tests including a rapid test 
for leptospirosis, serology with enzyme-linked immunosorbent assay (ELISA) and 
microscopic agglutination test (MAT), and polymerase chain reaction (PCR) on acute and 
convalescent sera, urine, sputum samples, and throat swabs. The finding that PCR on 
throat swabs was concordant with the PCR on acute serum samples was of interest, 
raising the possibility to employ throat swabs as alternative non-invasive samples for the 
diagnosis of acute leptospirosis. 
As it is well known that pneumonia is preceded by nasopharyngeal carriage of 
respiratory pathogens, part III explores the carriage rate of S. pneumoniae, K. 
pneumoniae, and other GNB in healthy individuals and compares the characteristics of 
these strains to those isolated from pneumonia patients. Chapter 5 and chapter 6 
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describe the results of our study on the nasopharyngeal carriage of S. pneumoniae, K. 
pneumoniae, and other GNB in healthy individuals and the analysis of the risk factors for 
carriage. The carriage rates of S. pneumoniae were 43% in children aged 6-60 months and 
11% in adults aged 45-70 years, which are comparable to those in other developed 
countries such as the Netherlands and Japan. The carriage rates of K. pneumoniae were 
7% in children and 15% in adults, while those for other GNB were 19% either in children or 
adults. These rates are much higher compared to those reported in developed countries. 
Throat carriage of GNB was associated with socio-economic circumstances, especially 
exposure to poor food and water hygiene. 
Chapter 7 presents the characteristic differences between K. pneumoniae isolated 
from healthy individuals and from CAP patients with regard to hypermucoviscosity, 
antimicrobial susceptibility profile, capsular types, and the presence of virulence factors 
rmpA and wcaG. Strains from healthy and pneumonic adults were more virulent than 
those from children, and seemed to come from closely related clones since they shared 
similarities with regard to hypermucoviscosity, capsular types, and the presence of rmpA 
and wcaG genes. Strains from healthy children seemed to be less virulent and to come 
from different clones as they differed from those from healthy adults with regard to 
hypermucoviscosity and the presence of wcaG genes. Thus, exposure to and throat 
carriage with GNB, specifically K. pneumoniae, may be especially important for the adult 
population, predisposing them to respiratory tract infections with such bacilli. 
Part IV, chapter 8 presents the development of indicators to assess the quality of care, 
notably that related to the antibiotic treatment in CAP patients. Using Delphi methods, 
only 6 out of 15 suggested valid quality indicators (QIs) were accepted. Most indicators 
were rejected because of poor feasibility to employ them in the clinical setting in 
Indonesian health care. To improve the development of the QIs, it is recommended to 
implement a modified Delphi method which includes a discussion between the rounds, to 
institute a sound medical documentation, and to improve the services of clinical 
microbiology laboratories in Indonesia. 
In part V, chapter 9 and 10, the main results are discussed and summarized. 
Suggestions for the improvement of health care practice and for further research are 
provided. 
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kenmerken van deze bacteriestammen met de stammen die geïsoleerd zijn van patiënten 
met longontsteking. Hoofdstuk 5 en hoofdstuk 6 beschrijven de resultaten van onze 
studie naar het dragerschap van S. pneumoniae, K. pneumoniae en andere GNB bij 
gezonde personen en de analyse van risicofactoren voor dat dragerschap. Nasofaryngeaal 
dragerschap van S. pneumoniae was 43% bij kinderen van 6-60 maanden en 11% bij 
volwassenen van 45-70 jaar, hetgeen vergelijkbaar is met het dragerschapspercentage in 
economisch ontwikkelde landen zoals Nederland en Japan. Nasofaryngeaal dragerschap 
van K. pneumoniae was 7% bij kinderen en 15% bij volwassenen, terwijl dat voor andere 
GNB 19% in beide groepen was. Deze percentages zijn veel hoger dan die gerapporteerd 
in economisch ontwikkelde landen. Dragerschap met GNB was geassocieerd met bepaalde 
socio-economische omstandigheden, met name blootstelling aan slechte water- en 
voedselhygiëne. 
Hoofdstuk 7 beschrijft in hoeverre K. pneumoniae stammen geïsoleerd van gezonde 
individuen en van CAP patiënten verschillen met betrekking tot hypermucoviscositeit, het 
antimicrobiële gevoeligheidsprofiel, kapseltypen en de aanwezigheid van de 
virulentiefactoren rmpA en wcaG. Bacteriestammen van gezonde volwassenen en 
volwassenen met longontsteking waren virulenter dan die van kinderen en leken 
afkomstig te zijn van nauw verwante klonen gelet op de overeenkomsten betreffende 
hypermucoviscositeit, kapseltypen en de aanwezigheid van rmpA en wcaG-genen. De 
bacteriestammen van gezonde kinderen leken minder virulent te zijn en van andere 
klonen te komen, want zij verschilden met die van gezonde volwassenen wat betreft 
hypermucoviscositeit en de aanwezigheid van wcaG-genen. Het nasofaryngeaal 
dragerschap van K. pneumoniae lijkt dus met name van belang bij volwassenen, omdat zij 
door deze blootstelling luchtweginfecties zouden kunnen krijgen met deze bacteriën. 
Deel IV, hoofdstuk 8, beschrijft de ontwikkeling van kwaliteitsindicatoren (QI) voor de 
beoordeling van de kwaliteit van de verleende zorg , inzake de behandeling van CAP 
patiënten met antibiotica. Met behulp van de Delphi-methode, werden slechts 6 van de 
15 voorgestelde QI’s uiteindelijk uitgekozen. De meeste indicatoren werden afgewezen 
vanwege de slechte uitvoerbaarheid. Ter verbetering van de ontwikkeling en de 
toepassing van de QI’s, is het raadzaam om een gemodificeerde Delphi-methode toe te 
passen, waarbij het mogelijk is om tijdens een bijeenkomst van deskundigen opinies uit te 
wisselen en aan elkaar te toetsen, om een zo goed mogelijke medische documentatie in 
het ziekenhuis op te zetten en om de dienstverlening van het microbiologisch 
laboratorium te verbeteren. 
In deel V, hoofdstuk 9 en 10, worden de belangrijkste resultaten samengevat en 
besproken. Tevens worden er aanbevelingen gedaan voor de verbetering van de 
gezondheidszorg en voor verder onderzoek. 
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Thuis-opgelopen longontsteking (“community-acquired pneumonie” of CAP) is één van 
de meest voorkomende infectieziekten in de wereld. In lage- en middeninkomenslanden is 
het één van de meest voorkomende oorzaken van mortaliteit en morbiditeit. Het doel van 
dit proefschrift was om de kennis over de klinische en microbiologische aspecten van CAP 
in Indonesië te vergroten. Deze informatie is nodig om wetenschappelijk goed 
onderbouwde richtlijnen te kunnen ontwikkelen voor de behandeling van patiënten met 
CAP in Indonesië. 
Deel I geeft achtergrondinformatie over CAP in Zuidoost-Azië. Hoofdstuk 2 geeft een 
overzicht van de literatuur over CAP in Zuidoost-Azië van januari 2000 tot december 2011 
met focus op de epidemiologie, klinische presentatie, etiologie, risicofactoren, 
behandeling en uitkomst. De algemene conclusie die getrokken kon worden was dat er 
zeer beperkt informatie over het onderwerp is. Slechts uit drie landen zijn 
onderzoeksgegevens gepubliceerd waarbij de onderzoeksmethoden varieerden tussen de 
verschillende landen en niet optimaal waren gestandaardiseerd.  
In deel II worden de karakteristieken van CAP patiënten, de verwekkers van CAP en de 
uitkomsten van de ziekenhuisopnamen onderzocht in twee ziekenhuizen in de stad 
Semarang, Midden-Java, Indonesië, met behulp van de meest recente diagnostische tests. 
Hoofdstuk 3 presenteert de resultaten van de prospectieve studie van 148 patiënten met 
CAP die in het ziekenhuis werden opgenomen. Het etiologische patroon van CAP bleek 
sterk te verschillen van dat in de economisch ontwikkelde landen in Europa, Noord-
Amerika en Australië. De respiratoire virussen waren het meest frequent aangetoond, 
namelijk bij 45% van de patiënten, met influenza A en B als meest voorkomende (18%). 
Gram-negatieve bacteriën (GNB), waaronder Klebsiella pneumoniae (14%) en andere GNB 
(5%) waren de meest voorkomende bacteriële oorzaak van CAP bij in het ziekenhuis 
opgenomen patiënten, gevolgd door Streptococcus pneumoniae (13%). Gemengde 
infecties kwamen veel voor. De mortaliteit onder de 148 patiënten was hoog (30%) en was 
geassocieerd met ernst van de ziekte en met het ontbreken van een etiologische 
diagnose. Hoofdstuk 4 rapporteert vijf patiënten met CAP bij wie de diagnose leptospirose 
vastgesteld werd met verscheidene onderzoeken:  sneltest voor leptospirose, serologie 
met een “enzyme-linked immunosorbent assay”-techniek (ELISA), microscopische 
agglutinatietest (MAT) en een polymerase kettingreactie (PCR) op serum uit de acute fase 
en de herstelfase, urine, sputum en keeluitstrijkjes. De bevinding dat het resultaat van de 
PCR op het keeluitstrijkje consistent was met de PCR op serum uit de acute fase is 
belangwekkend, omdat het de mogelijkheid biedt om keeluitstrijkjes te gebruiken als een 
niet-invasief alternatief voor de diagnose van leptospirose. 
Het is algemeen bekend dat longontsteking vaak wordt voorafgegaan door 
nasofaryngeaal dragerschap van respiratoire pathogenen. Deel III verkent het dragerschap 
van S. pneumoniae, K. pneumoniae en andere GNB bij gezonde individuen en vergelijkt de 
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met longontsteking. Hoofdstuk 5 en hoofdstuk 6 beschrijven de resultaten van onze 
studie naar het dragerschap van S. pneumoniae, K. pneumoniae en andere GNB bij 
gezonde personen en de analyse van risicofactoren voor dat dragerschap. Nasofaryngeaal 
dragerschap van S. pneumoniae was 43% bij kinderen van 6-60 maanden en 11% bij 
volwassenen van 45-70 jaar, hetgeen vergelijkbaar is met het dragerschapspercentage in 
economisch ontwikkelde landen zoals Nederland en Japan. Nasofaryngeaal dragerschap 
van K. pneumoniae was 7% bij kinderen en 15% bij volwassenen, terwijl dat voor andere 
GNB 19% in beide groepen was. Deze percentages zijn veel hoger dan die gerapporteerd 
in economisch ontwikkelde landen. Dragerschap met GNB was geassocieerd met bepaalde 
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dragerschap van K. pneumoniae lijkt dus met name van belang bij volwassenen, omdat zij 
door deze blootstelling luchtweginfecties zouden kunnen krijgen met deze bacteriën. 
Deel IV, hoofdstuk 8, beschrijft de ontwikkeling van kwaliteitsindicatoren (QI) voor de 
beoordeling van de kwaliteit van de verleende zorg , inzake de behandeling van CAP 
patiënten met antibiotica. Met behulp van de Delphi-methode, werden slechts 6 van de 
15 voorgestelde QI’s uiteindelijk uitgekozen. De meeste indicatoren werden afgewezen 
vanwege de slechte uitvoerbaarheid. Ter verbetering van de ontwikkeling en de 
toepassing van de QI’s, is het raadzaam om een gemodificeerde Delphi-methode toe te 
passen, waarbij het mogelijk is om tijdens een bijeenkomst van deskundigen opinies uit te 
wisselen en aan elkaar te toetsen, om een zo goed mogelijke medische documentatie in 
het ziekenhuis op te zetten en om de dienstverlening van het microbiologisch 
laboratorium te verbeteren. 
In deel V, hoofdstuk 9 en 10, worden de belangrijkste resultaten samengevat en 
besproken. Tevens worden er aanbevelingen gedaan voor de verbetering van de 
gezondheidszorg en voor verder onderzoek. 
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Pnemonia komunitas (PK) merupakan salah satu penyakit infeksi utama di seluruh 
dunia. Di negara-negara berpenghasilan rendah-menengah, penyakit ini merupakan salah 
satu penyebab kesakitan dan kematian terpenting. Tujuan thesis ini adalah untuk 
meningkatkan pengetahuan  tentang PK di Indonesia,  khususnya dalam aspek 
mikrobiologi dan aspek klinis. Informasi tersebut diperlukan agar dapat disusun suatu 
pedoman manajemen pasien PK yang berdasarkan bukti yang spesifik  dan sesuai untuk 
Indonesia. 
Bagian I membahas latar belakang informasi mengenai PK di Asia Tenggara.  Bab 2 
menyajikan  ikhtisar dari literatur-literatur  ilmiah mengenai PK di Asia Tenggara dari 
Januari 2000-Desember 2011 dengan fokus pada epidemiologi, penampilan klinis, etiologi, 
faktor risiko, pengelolaan, dan luaran pasien-pasien PK.  Sebagai kesimpulan umum, dapat 
dinyatakan bahwa  informasi mengenai PK di Asia Tenggara masih jarang karena hanya 
tiga Negara (Malaysia, Thailand, Singapura) yang pernah mempublikasikan hasil penelitian 
tentang PK. Selain itu, kebanyakan penelitian tidak menggunakan metode penelitian yang 
baku.  
Pada bagian II,  kami mengeksplorasi karakteristik pasien PK yang dirawat di di dua 
rumah sakit di kota Semarang, Jawa  Tengah,  pathogen-patogen penyebab PK dengan 
menggunakan pemeriksaan mikrobiologi mutakhir, serta luaran dari perawatan di rumah 
sakit. Bab 3 menyajikan  hasil penelitian prospektif berbasis rumah sakit yang mencakup 
148 pasien. Pola etiologi PK terbukti cukup berbeda dengan yang didapatkan di negara-
negara maju di Eropa, Amerika Utara, atau Australia.  Penyebab PK terbanyak pada 
penelitian ini adalah virus-virus respiratori, yang ditemukan pada 45% dari total pasien, 
dengan virus influenza A dan B sebagai etiologi yang paling sering (18%). 
Kuman bentuk batang Gram negatif (KBBGN), terdiri dari Klebsiella pneumonia (14%) 
dan KBBGN-lain (5%) merupakan penyebab bakterial paling sering pada pasien PK yang 
dirawat inap, diikuti oleh Streptococcus pneumoniae (13%). Infeksi polimikrobial juga 
sering didapatkan. Angka kematian-30-hari dari 148  pasien tersebut tinggi (30%) dan 
berhubungan secara signifikan dengan  derajat berat penyakit, dan kegagalan dalam 
menegakkan diagnosis etiologi. 
 Bab 4 berisi laporan kasus  leptospirosis  dengan manisfestasi klinik PK, yang 
didiagnosis dengan berbagai pemeriksaan mikrobiologi seperti  tes cepat (rapid test), 
serologi dengan  enzyme-linked immunosorbent assay (ELISA) dan microscopic 
agglutination test (MAT), and polymerase chain reaction (PCR) pada specimen serum  
akut-konvalesens,  urin, sputum, dan swab tenggorok.  Fakta bahwa hasil PCR pada swab 
tenggorok bersesuaian dengan hasil PCR pada sampel serum akut merupakan temuan 
yang menarik, menimbulkan harapan untuk menggunakan swab tenggorok sebagai 
alternative sampel non invasif untuk diagnosis leptospirosis. 
Sebagaimana telah banyak diketahui, pneumonia didahului oleh kolonisasi atau 
bawaan (carriage) patogen respiratori pada nasofaring, maka bagian III membahas 
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tentang  bawaan  S. pneumoniae, K. pneumonia pada individu sehat dan membandingkan 
karakteristik dari strain yang  diperoleh dari individu sehat tersebut dengan strain yang 
berasal dari pasien PK. Bab 5 dan bab 6 memaparkan hasil penelitian kami tentang 
bawaan S. pneumoniae, K. pneumoniae, dan KBBGN lainnya pada nasofaring individu 
sehat, serta faktor risiko bawaan patogen tersebut.  Angka bawaan S. pneumoniae  pada 
nasofaring didapatkan sebesar 43%  pada anak sehat usia 6-60 bulan dan 11% pada orang 
dewasa sehat usia 45-70 tahun. Angka ini hampir sebanding dengan yang didapatkan di 
Belanda dan Jepang.  Angka bawaan untuk K. pneumoniae sebesar  7% pada anak dan 15%  
pada orang dewasa, sedangkan untuk KBBGN lainnya sebesar 19% baik pada anak maupun 
dewasa. Angka bawaan KBBGN ini sangat tinggi dibandingkan dengan yang dilaporkan di 
negara maju.  Bawaan KBBGN pada tenggorok atau nasofaring berkaitan dengan 
lingkungan sosioekonomi, khususnya paparan terhadap air dan makanan dengan 
higienitas rendah. Bab 7 membandingkan perbedaan karakteristik strain K. pneumoniae 
yang diisolasi dari orang sehat dan dari pasien PK, khususnya dalam hal sifat 
hipermukoviskositas, profil kepekaan terhadap antibiotik, serta kepemilikan faktor 
virulensi rmpA dan wcaG. Strain dari individu dewasa  yang sehat maupun  yang sakit PK 
lebih virulen dari pada strain dari anak, dan tampaknya berasal dari klon yang 
berhubungan erat karena kemiripan karakteristik-karakteristik tersebut di atas. Strain dari 
anak sehat tampaknya kurang virulen dan berasal dari klon yang berbeda dari strain yang 
didapat dari orang dewasa sehat. Jadi, paparan dan bawan KBBGN, khususnya K.  
pneumonia, mungkin penting pada populasi dewasa, dan merupakan predisposisi 
terjadinya infeksi traktus respiratorius oleh KBBGN. 
Bagian IV, bab 8  membahas tentang pengembangan indikator kualitas (IK) perawatan, 
khususnya yang terkait dengan pengobatan antibiotik, pada pasien PK.  Dengan 
menggunakan metode Delphi, hanya 6 dari 15 indikator kualitas perawatan yang 
diusulkan oleh panel pakar terkait yang dapat digunakan. Sebagian besar indikator 
tertolak karena  kelayakannya terlalu rendah untuk digunakan pada sistem dan situasi 
perawatan kesehatan klinis  di Indonesia. Agar dapat dihasilkan IK perawatan yang lebih 
baik, direkomendasikan untuk menggunakan metode Delphi yang dimodifikasi dengan 
menambahkan diskusi di antara putaran pembentukan konsensus, menggunakan sistem 
dokumentasi  medis yang lebih baik, dan memperbaiki  pelayanan laboratorium 
mikrobiologi . 
Pada bagian V, bab 9 dan 10, hasil utama dari penelitian didiskusikan dan diringkas, 
disertai beberapa saran  untuk perbaikan dalam praktek pelayanan kesehatan di 
Indonesia.  
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tentang  bawaan  S. pneumoniae, K. pneumonia pada individu sehat dan membandingkan 
karakteristik dari strain yang  diperoleh dari individu sehat tersebut dengan strain yang 
berasal dari pasien PK. Bab 5 dan bab 6 memaparkan hasil penelitian kami tentang 
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